S266 3+6DYRLHHWDO

Version française Diagnostic local

Introduction Clinique

Epidémiologie
/HVWXPHXUVPDOLJQHVGXSpQLVVRQWUDUHV(Q)UDQFHOHXU
LQFLGHQFHHVWVWDEOH>@&HWDX[UDSSRUWpjODSRSXODWLRQ
PRQGLDOHVHUDLWGHSRXU7UqVUDUHVDYDQWDQV
FHVWXPHXUVDWWHLJQHQWVXUWRXWOHVSOXVGHDQV
,OV·DJLWG·XQHOpVLRQLQGXUpHGHYHUJHWRXFKDQWOHJODQGRX
OHSUpSXFHGDQVGHVFDV(OOHSHXWrWUHFDFKpHVRXVXQ
SKLPRVLV SURYRTXDQW XQ pFRXOHPHQW SXUXOHQW /·H[DPHQ
FOLQLTXH YLVH j UHFRQQDvWUH XQH H[WHQVLRQ XUpWUDOH GH OD
PDODGLHFDYHUQHXVHRXSpULQpDOH>@
Imagerie du pénis

Facteurs de risque
Échographie
• ,QIHFWLRQjhuman papillomavirusRX+39FRQG\ORPHV
YpQpULHQVSDSXORVHERZpQRwGH>@ /·pFKRJUDSKLHQ·HVWSDVO·H[DPHQGHUpIpUHQFHGDQVOHELODQ
• 3KLPRVLV HW GpIDXW G·K\JLqQH LQÁDPPDWLRQ FKURQLTXH G·H[WHQVLRQORFDOH&RXSOpDX'RSSOHUFRXOHXUFHWH[DPHQ
OHOLFKHQVFOpURDWURSKLTXHQHFRQVWLWXHSDVXQHOpVLRQ VLPSOHHWSHXFR€WHX[UHVWHRSpUDWHXUGpSHQGDQW,OSHUPHW
SUpFDQFpUHXVHSDUWHQDLUHVVH[XHOVPXOWLSOHVSXYDWKp- XQHDQDO\VHGHO·H[WHQVLRQORFDOHDXFRUSVFDYHUQHX[HWj
UDSLHSRXUSVRULDVLV O·XUqWUH>@/·pFKRVWUXFWXUHGHODWXPHXUHWFHOOHGHVFRUSV
VSRQJLHX[FDYHUQHX[VRQWSURFKHVPDLVOHVOLPLWHVWXPRUDOHV
UHVWHQWDVVH]QHWWHVVXUWRXWHQXWLOLVDQWGHVVRQGHVGHKDXWHV
Lésions précancéreuses IUpTXHQFHV!0K](OOHSHXWrWUHSUDWLTXpHVDQVRXDX
PLHX[DYHFXQHLQMHFWLRQLQWUDFDYHUQHXVHGHSURVWDJODQGLQHV
/DOpVLRQSUpFDQFpUHXVHODSOXVIUpTXHQWHHVWODQpRSODVLH
LQWUDpSLWKpOLDOH3H,1>@0DFURVFRSLTXHPHQWGLIIpUHQWVOH
carcinome in situO·pU\WKURSODVLHGH4XH\UDWRXODPDODGLH IRM
GH%RZHQGXSpQLVVRQWpTXLYDOHQWVDX3H,1KDXWJUDGHDX
QLYHDXKLVWRORJLTXH/HXUSULVHHQFKDUJHHVWLGHQWLTXH/HXU
DVVRFLDWLRQ DYHF XQH LQIHFWLRQ SDU +39 HVW SUREDEOHPHQW
VRXVpYDOXpHHWGRLWrWUHV\VWpPDWLTXHPHQWUHFKHUFKpH
'·DXWUHVOpVLRQVFRQVWLWXHQWGHVIRUPHVSUpFDQFpUHXVHV
RXFDQFpUHXVHVSUpLQYDVLYHVFRPPHOHFRQG\ORPHDFXPLQp
&·HVWXQHDOWHUQDWLYHRXXQFRPSOpPHQWGHO·pFKRJUDSKLH
/·H[DPHQ HVW VXSSRVp rWUH PRLQV RSpUDWHXU GpSHQGDQW
/·LQMHFWLRQLQWUDFDYHUQHXVHGHSURVWDJODQGLQHVSHUPHWG·REWH-
QLUXQHpUHFWLRQTXLIDFLOLWHODOHFWXUH>@/DOpVLRQHVWHQ
K\SRVLJQDO7SHXPDUTXp(OOHSUpVHQWHXQHUHVWULFWLRQHQ
JpDQW WXPHXU GH %XVFKNH/|ZHQVWHLQ RX OD PDODGLH GH GLIIXVLRQHWXQUHKDXVVHPHQWDSUqVLQMHFWLRQGHJDGROLQLXP
3DJHW H[WUDPDPPDLUH DGpQRFDUFLQRPH LQWUDpSLWKpOLDO
/HXUSULVHHQFKDUJHHVWO·H[pUqVHFKLUXUJLFDOHH[KDXVWLYH
Prévention
/DFLUFRQFLVLRQGDQVODSpULRGHQpRQDWDOHUpGXLUDLWOHULVTXH
GHFDQFHUGXSpQLVPDLVSDVGH3H,1>@/DFLUFRQFLVLRQj
O·kJHDGXOWHQ·HVWFHSHQGDQWSDVSUpYHQWLYH
'HSXLVÀQHQ)UDQFHOD+DXWH$XWRULWpGH6DQWp
/·LPDJHULHSDUUpVRQDQFHPDJQpWLTXH,50HVWSHUIRUPDQWH
SRXU O·H[WHQVLRQ DX FRUSV FDYHUQHX[ XQ SHX PRLQV SRXU
O·H[WHQVLRQ XUpWUDOH>@ (OOH HVW XWLOH HQ FDV GH FKLUXUJLH
FRQVHUYDWULFHHWLQGLVSHQVDEOHHQFDVGHFXULHWKpUDSLH
(QSUDWLTXHODSRVHG·XQHDQWHQQHSHOYLHQQHHVWFODV-
VLTXHVXUOHSpQLVGpFDORWWpHWVLSRVVLEOHHQpUHFWLRQ
Diagnostic anatomopathologique
+$6 UHFRPPDQGH HVVHQWLHOOHPHQW HQ SUpYHQWLRQ GHV
FDQFHUVDQDX[HWRURSKDU\QJpVXQHYDFFLQDWLRQGHWRXVOHV
JDUoRQVGHjDQVUpYROXVDYHFXQUDWWUDSDJHSRVVLEOH
GHjDQVUpYROXV/DYDFFLQDWLRQUHVWHUHFRPPDQGpH
MXVTX·jDQVSRXUOHVKRPPHVD\DQWGHVUHODWLRQVVH[XHOOHV
DYHFGHVKRPPHV>@&HODLQGXLWXQUHPERXUVHPHQW
/H &&$)8 VRXWLHQW XQH YDFFLQDWLRQ pODUJLH j WRXV OHV
Place de la biopsie
/DELRSVLHSHUPHWG·DIÀUPHUOHGLDJQRVWLFKLVWRORJLTXH(OOH
HVWREOLJDWRLUHDYDQWWRXWWUDLWHPHQWFRQVHUYDWHXUORFDO8QH
ELRSVLHH[pUqVHHVWSUpIpUpHSRXUXQHVWDGLÀFDWLRQ710HW
O·REWHQWLRQGXJUDGHRULHQWDQWDLQVLODSULVHHQFKDUJHGHV
KRPPHVMHXQHVDQVTXHOOHTXHVRLWOHXURULHQWDWLRQ DLUHVJDQJOLRQQDLUHV>@
VH[XHOOHDYHFXQUDWWUDSDJHSRVVLEOHMXVTX·jDQVHQFDV
GHUDSSRUWVKRPRVH[XHOV&HODSURWpJHUDLWOHVKRPPHVGHV
FDQFHUV+39LQGXLWVSpQLVDQXVRURSKDU\Q[PDLVDPpOLRUH- Histologie
UDLWDXVVLODSURWHFWLRQGHVMHXQHVÀOOHVQRQYDFFLQpHVFROGH
O·XWpUXVDQXVRURSKDU\Q[3OXVLHXUVYDFFLQVVRQWGLVSRQLEOHV /HFDUFLQRPHpSLGHUPRwGHUHSUpVHQWHSOXVGHGHVWXPHXUV
FRXYUDQW GLIIpUHQWV VRXVW\SHV GH +39 *DUGDVLOŠ apparaît PDOLJQHVGXSpQLV,OH[LVWHGHVIRUPHVPL[WHVFRPSUHQDQWGHV
VXIÀVDQWFDULOSURWqJHFRQWUHGHVFDQFHUV*DUGDVLOŠ FRQWLQJHQWVYHUUXTXHX[SDSLOODLUHERQSURQRVWLFRXEDVDORwGHV
SOXVRQpUHX[SURWqJHTXDQWjOXLFRQWUHGHVFDQFHUV>@ DGpQRVTXDPHX[VDUFRPDWRwGHVPDXYDLVSURQRVWLF>@
)UHQFKFF$)8JXLGHOLQHVîXSGDWHSHQLOHFDQFHU S267

Compte rendu anatomopathologique Tableau 1. &ODVVLÀFDWLRQ710GHVWXPHXUV

PDOLJQHVGXSpQLV
,OGRLWSUpFLVHUOHW\SHKLVWRORJLTXHOHJUDGHOHVWDGH7OH
T Tumeur primitive
VWDWXWS+39HWODPDUJHFKLUXUJLFDOH>@/DPDUJH
PLQLPDOHDXWRULVpHGpSHQGUDGXVWDGH710HWGXJUDGHGH pTx  HQVHLJQHPHQWVLQVXIÀVDQWVSRXUFODVVHU
5
ODWXPHXUPLQLPXPGHPPYRLUSOXVORLQ>@ ODWXPHXUSULPLWLYH
$XWRWDODXPRLQVXQWLHUVGHVFDUFLQRPHVpSLGHUPRwGHV 7 3DVGHVLJQHGHWXPHXUSULPLWLYH
VHUDLWDVVRFLpjXQHLQIHFWLRQSDU+39VRXVW\SHOHSOXV Tis Carcinome in situ
IUpTXHQWPDLVFHWWHIUpTXHQFHHVWSUREDEOHPHQWVRXVpYD- Ta &DUFLQRPHYHUUXTXHX[QRQLQÀOWUDQW
OXpH/DVXUYLHVSpFLÀTXHjDQVVHUDLWPHLOOHXUHSRXUOHV T1 7XPHXUHQYDKLVVDQWOHWLVVXFRQMRQFWLI
SDWLHQW+39TXHSRXUOHV+39²vs>@ sous-épithélial
T1a 7XPHXUHQYDKLVVDQWOHWLVVXFRQMRQFWLI
VRXVpSLWKpOLDOVDQVLQYDVLRQO\PSKRYDVFXODLUH
Tumeurs rares du pénis RXSpULQHXUDOHjO·H[FOXVLRQGXKDXWJUDGH
T1b JUDGHRXVDUFRPDWRwGH
/H PpODQRPH PDOLQ HVW j SUHQGUH HQ FKDUJH LQLWLDOHPHQW 7XPHXUHQYDKLVVDQWOHWLVVXFRQMRQFWLI
FRPPHWRXWHWXPHXUPDOLJQHGXSpQLV VRXVpSLWKpOLDODYHFLQYDVLRQO\PSKRYDVFXODLUH
/HVO\PSKRPHVDLQVLTXHGLIIpUHQWVW\SHVGHVDUFRPHV ou périneurale, ou de haut grade (grade 3
SpQLHQVRQWDXVVLpWpUDSSRUWpVHWUpSRQGHQWjXQHSULVHHQ RXVDUFRPDWRwGH
FKDUJHVSpFLÀTXH 7 7XPHXUHQYDKLVVDQWOHFRUSVVSRQJLHX[
Les métastases péniennes sont principalement le fait d’un DYHFRXVDQVLQYDVLRQGHO·XUqWUH
FDQFHUSURVWDWLTXHRXFRORUHFWDO T3 7XPHXUHQYDKLVVDQWOHFRUSVFDYHUQHX[
DYHFRXVDQVLQYDVLRQGHO·XUqWUH
T4 7XPHXUHQYDKLVVDQWG·DXWUHVVWUXFWXUHV
&ODVVLÀFDWLRQ7107DEOHDX DGMDFHQWHV
F1*DQJOLRQVUpJLRQDX[FOLQLTXHSDOSDWLRQ
/HVWDGH7LVFRUUHVSRQGjXQH3H,1GHKDXWJUDGH3H,1 RXLPDJHULH
8QHDWWHLQWHGXFKRULRQDYHFLQYDVLRQO\PSKRYDVFXODLUH Nx  HQVHLJQHPHQWVLQVXIÀVDQWVSRXUFODVVHU
5
7ERXXQJUDGHPR\HQjpOHYpQpFHVVLWHXQHH[SORUDWLRQ O·DWWHLQWHGHVJDQJOLRQVO\PSKDWLTXHVUpJLRQDX[
GHVDLUHVJDQJOLRQQDLUHV/·H[LVWHQFHG·XQHUXSWXUHFDSVX- (ganglions inguinaux)
ODLUHGDQVOHFXUDJHJDQJOLRQQDLUHHVWXQIDFWHXUSURQRVWLTXH 1 Pas de ganglion inguinal palpé
SpMRUDWLIPDMHXU N1 3DOSDWLRQG·XQVHXOJDQJOLRQXQLODWpUDOPRELOH
3DOSDWLRQGHJDQJOLRQVPXOWLSOHVRXELODWpUDX[
PRELOHV
Groupes à risque 1 *DQJOLRQVLQJXLQDX[À[pVRXJDQJOLRQVSHOYLHQV
N3 XQLODWpUDX[RXELODWpUDX[
/HSURQRVWLFGHVWXPHXUVGXSpQLVGpSHQGGXVWDGH710HW
S1*DQJOLRQVUpJLRQDX[SDWKRORJLTXHELRSVLH
GXJUDGHKLVWRORJLTXH>@
RXH[pUqVH
/HVJURXSHVjULVTXHVRQW>@
• OHVWXPHXUVjIDLEOHULVTXH≤S7* pNx  HQVHLJQHPHQWVLQVXIÀVDQWVSRXUFODVVHU
5
• OHVWXPHXUVGHULVTXHLQWHUPpGLDLUHS7* O·DWWHLQWHGHVJDQJOLRQVO\PSKDWLTXHVUpJLRQDX[
• OHVWXPHXUVjKDXWULVTXHS7*S7* (ganglions inguinaux)
/·DWWHLQWH O\PSKRYDVFXODLUH GX FKRULRQ O·DWWHLQWH S1 Pas d’atteinte ganglionnaire régionale
périneurale et la profondeur de l’atteinte ont un fort pN1 ≤ 2 métastases ganglionnaires inguinales
LPSDFW SURQRVWLTXH SpMRUDWLI >@ /D YDOHXU SURQRV- unilatérales sans extension extra-capsulaire
WLTXH GH O·DWWHLQWH XUpWUDOH HVW GLVFXWpH VDXI GDQV VD S1 ≥ 3 métastases ganglionnaires inguinales
forme proximale où l’atteinte en profondeur est plus XQLODWpUDOHVRXDWWHLQWHELODWpUDOH
SpMRUDWLYH>@ sans extension extra-capsulaire
6HXOHV OHV DLUHV JDQJOLRQQDLUHV GHV WXPHXUV GH IDLEOH pN3 0pWDVWDVHJDQJOLRQQDLUHSHOYLHQQHH[WHQVLRQ
ULVTXH SHXYHQW rWUH VXUYHLOOpHV XQH DQDO\VH KLVWRORJLTXH extra-capsulaire
JDQJOLRQQDLUHHVWQpFHVVDLUHGDQVWRXVOHVDXWUHVFDV M Métastases à distance
Mx  HQVHLJQHPHQWVLQVXIÀVDQWVSRXUFODVVHU
5
GHVPpWDVWDVHVjGLVWDQFH
Diagnostic ganglionnaire et métastatique 0 3DVGHPpWDVWDVHjGLVWDQFH
M1 3UpVHQFHGHPpWDVWDVHVjGLVWDQFH
Grade histologique
Sémiologie
Gx  HQVHLJQHPHQWVLQVXIÀVDQWVSRXUFODVVHU
5
La présence d’adénopathie inguinale, premier relais de OHJUDGHKLVWRORJLTXH
GLIIXVLRQ PpWDVWDWLTXH GH OD WXPHXU SULPLWLYH GRLW rWUH G1 Bien différencié
LPSpUDWLYHPHQW UHFKHUFKpH SDU OD SDOSDWLRQ /HV DGpQR- * 0R\HQQHPHQWGLIIpUHQFLp
SDWKLHV SHXYHQW rWUH DEVHQWHV F1 PRELOHV F1F1 G3 )DLEOHPHQWGLIIpUHQFLp
G4 ,QGLIIpUHQFLp
6 3+6DYRLHHWDO

RX À[pHV F1 'DQV FHUWDLQV FDV XQH VXULQIHFWLRQ DYHF
ÀVWXOLVDWLRQjODSHDXSHXWrWUHOHPRWLIGHFRQVXOWDWLRQ
Examens paracliniques
Place de la cytoponction
/D F\WRSRQFWLRQ j O·DLJXLOOH VRXV pFKRJUDSKLH Q·D DXFXQ
LQWpUrWFKH]OHVSDWLHQWVF1
(QFDVGHJDQJOLRQSDOSDEOHODF\WRSRQFWLRQjO·DLJXLOOH
ÀQH HVW XQ JHVWH GH UpDOLVDWLRQ VLPSOH HQ FRQVXOWDWLRQ HW
SHXPRUELGH(OOHHVWSURSRVpHVLXQJDQJOLRQHVWSDOSp>@
(OOH Q·D GH YDOHXU TXH VL HOOH HVW SRVLWLYH HW SHUPHW GDQV
FDYHUQHX[ HW XUqWUH PDLV PHLOOHXUH SRXU O·H[WHQVLRQ
JDQJOLRQQDLUH HW j GLVWDQFH 6D VHQVLELOLWp HVW YDULDEOH
VHORQO·H[DPHQFOLQLTXHHQWUHHWSRXUOHVSDWLHQW
F1DYHFXQHERQQHVSpFLILFLWpGHj>@
SRXUOHVSDWLHQWVF1SRXUXQHVSpFLILFLWpGH>@
&HV YDOHXUV OD UHQGHQW SHUWLQHQWH GDQV O·pYDOXDWLRQ GH
O·HIILFDFLWpG·XQHFKLPLRWKpUDSLHQpRDGMXYDQWHFKH]OHV
SDWLHQWV1
Ganglion sentinelle inguinal
6RQSULQFLSHHVWOHUHSpUDJHGHODYRLHGHGUDLQDJHO\PSKD-
WLTXHGXSpQLVSDUXQHWHFKQLTXHG·LPDJHULHQXFOpDLUHVXLYL
GHO·DQDO\VHDQDWRPRSDWKRORJLTXHGXUHODLVJDQJOLRQQDLUH
FHFDVGHJDJQHUGXWHPSVHQEDVFXODQWGLUHFWHPHQWGDQV OH SOXV SUR[LPDO JDQJOLRQ VHQWLQHOOH DSUqV SUpOqYHPHQW
ODSULVHHQFKDUJHWKpUDSHXWLTXHLGRLQHODSOXVDJUHVVLYH FKLUXUJLFDO /·DQDO\VH GRLW rWUH ELODWpUDOH ,QLWLDOHPHQW
FXUDJHLQJXLQDOUDGLFDOGXF{Wp1HWH[SORUDWLRQLQJXLQDOH FULWLTXpHSRXUXQWDX[GHIDX[QpJDWLIVGHVDSUDWLTXH
LQYDVLYHGXF{WpF1>JDQJOLRQVHQWLQHOOHRXFXUDJHPRGL- GDQVGHVFHQWUHVH[SpULPHQWpVSHUPHWG·DEDLVVHUOHWDX[
Àp@ 8QH F\WRSRQFWLRQ SRVLWLYH SHUPHW DXVVL G·LQFOXUH j j>@
FHVWDGHOHVSDWLHQWVGDQVO·pWXGH$)8*(78*B0(*$&(3
1&7>@
8QH F\WRORJLH QpJDWLYH QH PHW SDV ÀQ j OD SKDVH GLD-
JQRVWLTXH(OOHQ·pFDUWHSDVXQHQYDKLVVHPHQWPpWDVWDWLTXH
JDQJOLRQQDLUH(OOHSHXWrWUHpYHQWXHOOHPHQW UpSpWpHXQH
IRLVVLQRQHOOHGRLWFRQGXLUHjXQFXUDJHPRGLÀpELODWpUDO
GLDJQRVWLTXH &H GHUQLHU QH GRLW SDV rWUH GLIIpUp SDU XQH
DQWLELRWKpUDSLHSUREDELOLVWH
Imagerie inguinale
Échographie/TDM/IRM
&HVH[DPHQVVRQWLQGLTXpVVLO·H[DPHQFOLQLTXHQHSHUPHW
(QO·DEVHQFHGHPLJUDWLRQXQLRXELODWpUDOHGXUDGLR-
WUDFHXU RQ SHXW UpSpWHU OD SURFpGXUH j GLVWDQFH FH TXL
SHUPHWWUDLW GH ORFDOLVHU OH JDQJOLRQ VHQWLQHOOH PDQTXDQW
GDQVGHVFDV>@
Bilan d’extension pelvien et à distance
,QGLTXpHQFDVGHSRVLWLYLWpFOLQLTXHDQDWRPRSDWKRORJLTXH
GHVJDQJOLRQVLQJXLQDX[FHELODQSHXWrWUHHIIHFWXpLGpD-
OHPHQWSDUXQH7(3)'*VLQRQSDUXQVFDQQHUWKRUDFR
DEGRPLQRSHOYLHQDYHFLQMHFWLRQGHSURGXLWGHFRQWUDVWH
La scintigraphie osseuse n’est recommandée qu’en cas de
point d’appel osseux ou d’hypercalcémie.
SDVO·pYDOXDWLRQJDQJOLRQQDLUHRSWLPDOHREpVLWp«
Tableau de recommandation 1. Recommandations
Échographie inguinale GLDJQRVWLTXHVGHVWXPHXUVPDOLJQHVGXSpQLV
(OOHHVWSHXFR€WHXVHHWODSOXVDFFHVVLEOH(OOHGpSLVWHOHV
adénopathies suspectes (perte du hile graisseux, augmenta- Tumeur pénienne Grade
WLRQGXUDWLRpSDLVVHXUORQJXHXUHWSHUPHWDORUVGHJXLGHU
([DPHQFOLQLTXHGHVFULSWLRQORFDOLVDWLRQ Fort
XQHF\WRSRQFWLRQVLO·DGpQRSDWKLHQ·HVWSDVSDOSDEOH>@
H[WHQVLRQORFDOHHQYDKLVVHPHQWGHYRLVLQDJH
7RPRGHQVLWRPpWULHLQJXLQDOH eFKRJUDSKLHRX,50HQpUHFWLRQLQGXLWHDYDQW Faible
(OOHHVWLQGLTXpHGDQVXQELODQG·H[WHQVLRQJpQpUDOVFDQQHU FKLUXUJLHFRQVHUYDWULFH
WKRUDFRDEGRPLQRSHOYLHQTXDQGQpFHVVDLUH/HFKDPSG·DF-
TXLVLWLRQGHYUDGHVFHQGUHMXVTX·HQEDVGHVDLUHVLQJXLQDOHV8Q Aires ganglionnaires
H[DPHQXQLTXHPHQWFHQWUpVXUOHVDLUHVLQJXLQDOHVQ·HVWSDV ([DPHQ F1HW<S7* 6XUYHLOODQFH Fort
LQGLTXp(OOHQHGpWHFWHSDVOHVPLFURPpWDVWDVHVHWQHSHXW &OLQLTXH ou supposé
GRQFVHVXEVWLWXHUjXQHpYDOXDWLRQJDQJOLRQQDLUHLQYDVLYH “'RSSOHU
RX7'0 F1HW!S7* eYDOXDWLRQ Fort
,PDJHULHSDUUpVRQDQFHPDJQpWLTXH ou supposé LQYDVLYH
/HVDLUHVLQJXLQDOHVGRLYHQWrWUHpYDOXpHVORUVGHO·,50GpGLpH
DXELODQORFDO8QH,50SHOYLHQQHQ·DSDVVDSODFHGHIDoRQLVR- F1 Cytoponction Fort
OpHSRXUOHELODQORFRUpJLRQDOFDUWRXWFRPPHOHVFDQQHUO·,50 7(3VFDQQHU
QHSHUPHWSDVOHGpSLVWDJHGHVPLFURPpWDVWDVHV/·XWLOLVDWLRQ Métastases
GHSURGXLWGHFRQWUDVWHVXSHUSDUDPDJQpWLTXHQ·DSOXVVDSODFH
HQ)UDQFHDFWXHOOHPHQWSURGXLWUHWLUpGXPDUFKp>@ 1 Bilan d’extension par scanner Fort
7$3RX7(3VFDQQHU
Tomographie par émission de positrons au 18F-FDG
Suspicion Scintigraphie osseuse en Fort
/·XWLOLVDWLRQ GX 7(37'0 DX )'* HVW FURLVVDQWH 6D
FOLQLTXH0 FRPSOpPHQWGHOD7(3
VHQVLELOLWp HVW IDLEOH SRXU O·H[WHQVLRQ ORFDOH FRUSV
)UHQFKFF$)8JXLGHOLQHVîXSGDWHSHQLOHFDQFHU S269

Traitement de la tumeur pénienne GRVHGpOLYUpHHVWVXSpULHXUHj*\/HVFRPSOLFDWLRQVVRQW

OHVVWpQRVHVGXPpDWOHVGRXOHXUVHWOHVQpFURVHVGXJODQG
/DUDGLRWKpUDSLHH[WHUQHHVWSHXXWLOLVpHHQ)UDQFH6RQ
Modalités thérapeutiques LQWpUrWQ·HVWSDVQRQSOXVGpPRQWUpHQSDOOLDWLI

Traitements conservateurs locaux ,QGLFDWLRQVWKpUDSHXWLTXHV7DEOHDX

/RUVTX·XQWUDLWHPHQWFRQVHUYDWHXUORFDOQRQFKLUXUJLFDOHVW
HQYLVDJpXQHELRSVLHHVWREOLJDWRLUHDLQVLTX·XQHFLUFRQFL- Stade Tis
VLRQ&HWWHSULVHHQFKDUJHH[SRVHjGHVUpFLGLYHVSUpFRFHV
YRLUSOXVORLQFHTXLLPSRVHXQFRQWU{OHKLVWRORJLTXHDX 8QWUDLWHPHQWFRQVHUYDWHXUORFDOSDUFUqPHF\WRWR[LTXHRX
PRLQGUHGRXWHORUVGHODVXUYHLOODQFHHWXQHELRSVLHV\VWp- ODVHUHVWSRVVLEOHVDXIHQFDVG·DWWHLQWHGXPpDWMXVTX·j
PDWLTXHGDQVOHVDQVHQFDVGHFDUFLQRPHin situ&,6 GHUpFLGLYHVSRXUOHVTXHOOHVXQGHX[LqPHWUDLWHPHQW
Les modalités de prise en charge sont : ORFDO HVW FRQWUHLQGLTXp >@ 8Q FRQWU{OH ELRSVLTXH HVW
• FUqPHVF\WRWR[LTXHV,PLTXLPRGDSSOLFDWLRQVSDU REOLJDWRLUHGDQVOHVDQV
VHPDLQHSHQGDQWjVHPDLQHVRX)8DSSOLFDWLRQV 8QWUDLWHPHQWFKLUXUJLFDOFRQVHUYDWHXUHVWUHFRPPDQGp
SDUMRXUSHQGDQWjVHPDLQHV>@ 8QHFLUFRQFLVLRQHVWFRQVHLOOpH/DWHFKQLTXHGH©UHVXUID-
• laser Yag ou CO2 ; oDJHªGXJODQGDYHFJUHIIHFXWDQpHGRQQHDXMRXUG·KXLOHV
• SKRWRWKpUDSLHG\QDPLTXHDSUqVDSSOLFDWLRQG·XQWRSLTXH PHLOOHXUVUpVXOWDWVHQWHUPHVGHUpFLGLYHV>@
SKRWRVHQVLELOLVDQWDPLQROpYXOLQDWHGHPpWK\OHFRPPHU-
FLDOLVpVRXVOHQRP0(79,;,$ŠPJJFUqPH,OV·DJLW
G·XQH RSWLRQ GH GHX[LqPH LQWHQWLRQ FKH] GHV VXMHWV
7DEOHDX,QGLFDWLRQVWKpUDSHXWLTXHVHQIRQFWLRQ
LPPXQRFRPSpWHQWV>@
GXVWDGH7
(QFDVG·pFKHFXQeHVVDLGHWUDLWHPHQWSDUWRSLTXHV
RXODVHUQ·HVWSDVUHFRPPDQGp Stade T (type Options thérapeutiques Grade
GHOpVLRQ

Traitement chirurgical Tis &UqPHVF\WRWR[LTXHVSXLV Fort

VXUYHLOODQFHUDSSURFKpH
/D FKLUXUJLH GRLW rWUH OD SOXV FRQVHUYDWULFH SRVVLEOH 8QH Laser CO2 ou Yag puis
SRVWKHFWRPLH FLUFRQFLVLRQ GRLW rWUH V\VWpPDWLTXHPHQW VXUYHLOODQFHUDSSURFKpH
UpDOLVpH 'HV WHFKQLTXHV GH UHFRQVWUXFWLRQ SDU JUHIIH RX Biopsie-exérèse ou resurfaçage
ODPEHDX[FXWDQpVGRLYHQWSDUIRLVrWUHDVVRFLpHV>@
3KRWRWKpUDSLHG\QDPLTXHDYHF Faible
8Q H[DPHQ DQDWRPRSDWKRORJLTXH H[WHPSRUDQp GHV
ELRSVLHGHFRQWU{OHREOLJDWRLUH
marges chirurgicales est recommandé en cas de doute ou
GHOpVLRQYROXPLQHXVHHQFDVGH&,6FHWWHDQDO\VHH[WHP- Ta, T1a Curiethérapie Fort
SRUDQpHQ·HVWSDVLQGLVSHQVDEOH
8QHPDUJHQpJDWLYHHVWXQLPSpUDWLIDEVROXGRQFXQH Laser CO2 ou Yag puis Fort
PDUJH SRVLWLYH GRLW rWUH UHSULVH FKLUXUJLFDOHPHQW ULVTXH VXUYHLOODQFHUDSSURFKpH
GHUpFLGLYHPXOWLSOLpSDU>@8QHPDUJHGHVpFXULWpGH %LRSVLHH[pUqVHUHVXUIDoDJH Fort
PPHVWXQPLQLPXPUHTXLV&HUWDLQVSURSRVHQWGHVPDUJHV glandulectomie
GHVpFXULWpHQIRQFWLRQGHO·DJUHVVLYLWpGHODWXPHXUDLQVLLO
IDXGUDLWDYRLUPPSRXUOHVWXPHXUVGHJUDGHPPSRXU 7E7 %LRSVLHH[pUqVHJODQGXOHFWRPLH Fort
OHVJUDGHVHWPPSRXUOHVJUDGHV>@/DWHFKQLTXH
chirurgicale n’est donc pas standardisée mais fonction de la Curiethérapie Fort
WDLOOHHWGHODORFDOLVDWLRQGHODWXPHXU Amputation partielle (dans Fort
(Q FDV G·DPSXWDWLRQ SDUWLHOOH OD ORQJXHXU GX SpQLV des cas sélectionnés)
UHVWDQW GRLW rWUH DX PRLQV GH  FP SRXU SHUPHWWUH GHV
PLFWLRQVGDQVGHERQQHVFRQGLWLRQVVLQRQRQSURSRVHUDXQH T3 proximaux $PSXWDWLRQSDUWLHOOHVLSRVVLEOH Fort
XUpWURVWRPLH SpULQpDOH /·DPSXWDWLRQ WRWDOH LPSRVH XQH
T3 du corps Amputation totale et Fort
XUpWURVWRPLH SpULQpDOH /·pPDVFXODWLRQ HW OD GpVLQVHUWLRQ
du pénis urétrostomie périnéale
FRPSOqWHGHVFRUSVFDYHUQHX[VRQWXQLTXHPHQWGHVJHVWHV
GHQpFHVVLWpFDUFLQRORJLTXH T4 &KLPLRWKpUDSLHQpRDGMXYDQWH Fort
HWDPSXWDWLRQFKH]OH
répondeur
4.1.3. Radiothérapie
Récidive &KLUXUJLHFRQVHUYDWULFH Faible
8QH FLUFRQFLVLRQ SUpDODEOH HVW V\VWpPDWLTXH DYDQW WRXWH locale après VLOHVFRUSVFDYHUQHX[QHVRQW
FXULHWKpUDSLHRXUDGLRWKpUDSLH chirurgie SDVHQYDKLV
/DFXULHWKpUDSLHLQWHUVWLWLHOOHSDUÀOVG·LULGLXPHVW conservatrice
Amputation partielle ou totale Faible
ODWHFKQLTXHGHFKRL[HWODVHXOHXWLOLVpHHQ)UDQFH>@/D
S270 3+6DYRLHHWDO

Stades Ta/T1a VRXYHQW DVVRFLpV FKLPLRWKpUDSLH QpRDGMXYDQWH RX DGMX-

'DQV WRXV OHV FDV XQHFLUFRQFLVLRQHVW UpDOLVpHDYDQWXQH
excision par laser Yag ou CO2 8Q WUDLWHPHQW FKLUXUJLFDO
FRQVHUYDWHXUSDUELRSVLHH[pUqVHHWFLUFRQFLVLRQSHXWrWUH
UpDOLVpRXXQ©UHVXUIDoDJHªGXJODQGDYHFJUHIIHFXWDQpH
YRLUHXQHJODQGXOHFWRPLHDYHFFRXYHUWXUHSDUJUHIIHFXWDQpH
8QHFXULHWKpUDSLHSHXWrWUHSURSRVpHSRXUGHVWXPHXUV
GHPRLQVGHFP>@
YDQWHpWXGH$)8*(78*B0(*$&(31&7>@
Curage ganglionnaire
3RXUWDQWHQFRUHGpFULWHGDQVFHUWDLQVRXYUDJHVGHUpIpUHQFH
ODWHFKQLTXHGHFXUDJHPRGLÀpVHORQ&DWDORQDHVWREVROqWH
/HLMWHHWDORQWPRQWUpVXUF1TXHOHVSUHPLHUVUHODLV
JDQJOLRQQDLUHVVHWURXYDLHQWGDQVSOXVGHGHVFDVGDQV
OHVTXDGUDQWVVXSpULHXUVHWOHTXDGUDQWFHQWUDOGHV]RQHV
6WDGH7E7GXJODQG GH'DVHOHU)LJXUH'pVRUPDLVOHFXUDJHLQJXLQDOPRGLÀp
FRQFHUQHOHVTXDGUDQWVVXSpULHXUHWFHQWUDODXWRXUGHOD
8QWUDLWHPHQWFRQVHUYDWHXUHVWUHFRPPDQGpHQO·DEVHQFH
G·HQYDKLVVHPHQWXUpWUDO,OFRQVLVWHHQXQHELRSVLHH[pUqVH
DYHFFLUFRQFLVLRQ8QHJUHIIHFXWDQpHSHXWrWUHSURSRVpHVL
QpFHVVDLUH6LODWXPHXURFFXSHSOXVGHODPRLWLpGXJODQG
XQHJODQGXOHFWRPLHDYHFFLUFRQFLVLRQHVWUHFRPPDQGpH>@
8QHFXULHWKpUDSLHSHXWrWUHSURSRVpHSRXUOHVWXPHXUVGH
YHLQHVDSKqQHFKH]OHVSDWLHQWVF1jULVTXH>@
La lymphadénectomie inguinale totale (ou radicale)
FRQVLVWHHQXQHDEODWLRQGHWRXVOHVJDQJOLRQVLQJXLQDX[GX
WULDQJOHGH6FDUSD
&HFXUDJHPHQDFHOHGUDLQDJHO\PSKDWLTXHGXPHPEUH
LQIpULHXU HW OD YDVFXODULVDWLRQ FXWDQpH /D PRUELGLWp GH
PRLQVGHFPGXJODQGRXGXVLOORQEDODQRSUpSXWLDOVLWXpHV FH FXUDJH HVW OLpH DX[ ULVTXHV GH O\PSKRFqOH 
jGLVWDQFHGHO·XUqWUHHWGHVRQPpDWVDQVHQYDKLVVHPHQW QpFURVHFXWDQpHLQIHFWLRQSDULpWDOH
GHO·DOEXJLQpHGHVFRUSVFDYHUQHX[>@ O\PSK±GqPH>@/HVVpULHVUDSSRUWHQWXQH
8QJHVWHQRQFRQVHUYDWHXUjW\SHG·DPSXWDWLRQSDUWLHOOH PRUELGLWpDXWRXUGH>@HWSHXYHQWDWWHLQGUH
peut se discuter en fonction de la compliance du patient et HQFDVG·REpVLWp>@
GHODVLWXDWLRQGHODWXPHXUDWWHLQWHSUR[LPDOH
6WDGH7HQYDKLVVDQWOHFRUSVGXSpQLV
Une amputation partielle est le traitement recommandé en
FDVG·DWWHLQWHGLVWDOH
'DQVOHVFDVG·DWWHLQWHSUR[LPDOHGXFRUSVGXSpQLVXQH
DPSXWDWLRQWRWDOHHVWUHFRPPDQGpH
/DPRUELGLWpSRVWRSpUDWRLUHHVWGLPLQXpHSDUO·XWLOLVD-
WLRQGHOLJDWXUHVDXÀO>@ODSUpVHUYDWLRQGHODYHLQH
VDSKqQHO·XWLOLVDWLRQG·XQSDQVHPHQWFRPSUHVVLIGHEDVGH
FRQWHQWLRQYRLUHG·XQHDQWLELRWKpUDSLHSUREDELOLVWH>@8Q
SDQVHPHQWjSUHVVLRQQpJDWLYHSHXWrWUHXWLOLVpHQSUpYHQ-
WLRQFRPPHHQWUDLWHPHQWGHVFRPSOLFDWLRQVO\PSKDWLTXHV
HWFXWDQpHV>@

Stade T3

8QH DPSXWDWLRQ SDUWLHOOH HVW LQGLTXpH HQ FDV G·DWWHLQWH

GLVWDOHVDQVH[WHQVLRQjO·XUqWUHSUR[LPDOVLODORQJXHXUGX
SpQLVUHVWDQWHVWVXIÀVDQWHFP
'DQV OHV FDV G·DWWHLQWH SUR[LPDOH GX FRUSV GX SpQLV
XQH DPSXWDWLRQ WRWDOH DYHF XUpWURVWRPLH SpULQpDOH HVW
UHFRPPDQGpH

Stade T4

8QHDPSXWDWLRQSpQLHQQHWRWDOHDYHFXUpWURVWRPLHSpULQpDOHHVW
UHFRPPDQGpHVLODWXPHXUHVWH[WLUSDEOHpYHQWXHOOHPHQWDVVR-
FLpHjXQHFKLPLRWKpUDSLHQpRDGMXYDQWH­FHVWDGHOHVWDX[
GHJXpULVRQVVRQWIDLEOHVHWODPRUELGLWppOHYpH>@

Traitement des aires ganglionnaires

inguinales et pelviennes
Figure 1. 7RSRJUDSKLHGHVWHUULWRLUHVGHGUDLQDJHO\PSKDWLTXH
LQJXLQDOVHORQ'DVHOHU
Modalités thérapeutiques /H FXUDJH PRGLÀp UHFRPPDQGp FRQFHUQH OHV WHUULWRLUHV
SpULVDSKqQHVXSpURLQWHUQHHWVXSpURH[WHUQH
La lymphadénectomie est le traitement de choix des adé- Les territoires inféro-internes (3) et inféro-externes (4) ne
QRSDWKLHV ORFRUpJLRQDOHV 'HV WUDLWHPHQWV FRPELQpV VRQW VRQWFRQVLGpUpVTXHGDQVOHFXUDJHUDGLFDO
)UHQFKFF$)8JXLGHOLQHVîXSGDWHSHQLOHFDQFHU 6

/·DERUGHQGRVFRSLTXHODSDURVFRSLTXHRXURERWDVVLVWp PROpFXOHV'HVUpSRQVHVjODEOpRP\FLQHHWDXPpWKRWUH[DWH

HVW HQYLVDJHDEOH FKH] FHUWDLQV SDWLHQWV ELHQ VpOHFWLRQQpV RQWpWpUDSSRUWpHV>@3L]]RFDURHWDORQWpYDOXpFKH]
F1HWGLPLQXHUDLWODPRUELGLWpGDQVFHUWDLQHVVpULHV>@  SDWLHQWV DSUqV XQ FXUDJH LQJXLQDO WRWDO ELODWpUDO XQH
/D O\PSKDGpQHFWRPLH SHOYLHQQH GRLW LQWpUHVVHU OHV FKLPLRWKpUDSLHDVVRFLDQWEOpRP\FLQHYLQFULVWLQHHWPpWKR
FKDvQHVJDQJOLRQQDLUHVLOLDTXHVH[WHUQHLQWHUQHHWSUL- WUH[DWHQ·RQWSDVGpYHORSSpGHUpFLGLYHGXUDQWODSpULRGH
PLWLYH(OOHGRLWrWUHUpDOLVpHVLSRVVLEOHVLPXOWDQpPHQWDX
curage inguinal (si l’examen extemporané la retient) sinon
HOOHGRLWrWUHIDLWHVDQVGpODLVLOHVUpVXOWDWVKLVWRORJLTXHV
GpÀQLWLIVO·LPSRVHQW>@
Radiothérapie externe
,OQ·\DSDVG·LQGLFDWLRQjXQHUDGLRWKpUDSLHLQJXLQDOHSUR-
SK\ODFWLTXHFKH]GHVSDWLHQWVF1>@
Aucun effet curatif de la radiothérapie n’a été démontré
GHVXLYLPRLVHQPR\HQQH>@'HVUpVXOWDWVGDQVFHVHQV
RQWpWpREWHQXVDYHFXQSURWRFROH%03SDU+DNHQEHUJ>@
/·DYDQWDJHGHODFKLPLRWKpUDSLHDGMXYDQWHHVWGHUpD-
OLVHUOHWUDLWHPHQW XQHIRLVOHVWDWXWJDQJOLRQQDLUHFRQQX
&HSHQGDQWGXIDLWGHVFRPSOLFDWLRQVHWGHODPRUELGLWpGH
ODFKLUXUJLHFHOOHFLQ·HVWSDVWRXMRXUVSRVVLEOHRXDXPRLQV
GpFDOpHGDQVOHWHPSV
/HVGHX[DXWUHVSURGXLWVD\DQWIDLWSUHXYHG·XQHFHUWDLQH
HIÀFDFLWp VRQW OH ÁXURXUDFLO HW O·LIRVIDPLGH 8QH pWXGH
UpFHQWHUpWURVSHFWLYH >@DLQVLTX·XQHpWXGHSURVSHFWLYH
GH SKDVH ,, QH VXSSRUWHQW SDV FHSHQGDQW O·XWLOLVDWLRQ GH
FKH]OHVSDWLHQWVS1TXHFHVRLWHQDGMXYDQWRXHQQpR O·DVVRFLDWLRQ73) GRFpWD[HO FLVSODWLQH HW )8 GX IDLW
DGMXYDQW/DFKLUXUJLHG·H[pUqVHIDLWPLHX[TXHODUDGLRWKp- HQSDUWLFXOLHUG·XQHWR[LFLWpLPSRUWDQWH>@/·DVVRFLDWLRQ
UDSLH>@/DUDGLRWKpUDSLHQ·HVWGRQFSDVUHFRPPDQGpHHQ WD[ROLIRVIDPLGHHWFLVSODWLQHVHPEOHSUpVHQWHUXQUDSSRUW
SUHPLqUHOLJQHFXUDWLYHGDQVOHWUDLWHPHQWGHVPpWDVWDVHV HIÀFDFLWpWR[LFLWpDFFHSWDEOH
JDQJOLRQQDLUHVGHVWXPHXUVGXSpQLV/DFKLPLRWKpUDSLHDGMX-
YDQWHVHUDLWSUpIpUDEOHjODUDGLRWKpUDSLHDGMXYDQWH>@
/DUDGLRWKpUDSLHDGMXYDQWHHVWXQHRSWLRQ Immunothérapie
• FKH] OHV SDWLHQWV F1 DYHF H[WHQVLRQ H[WUDFDSVXODLUH
LQJXLQDOHRXLOLDTXH /·LPPXQRWKpUDSLHHVWHQFRXUVG·pYDOXDWLRQGDQVOHVWXPHXUV
• en traitement palliatif pour les adénopathies inextir- GX SpQLV HQ HQWUHWLHQ FKH] OHV SDWLHQWV UpSRQGHXUV j OD
SDEOHVFKLUXUJLFDOHPHQW FKLPLRWKpUDSLHpWXGH38/6(>@

Chimiothérapie Indications thérapeutiques

/DFKLPLRWKpUDSLHDpWppYDOXpHHQVLWXDWLRQQpRDGMXYDQWH
FKH]OHVSDWLHQWVDWWHLQWVG·XQFDQFHUGXSpQLVORFDOHPHQW 6WDGHF1)LJXUH
DYDQFp F1 HQ VLWXDWLRQV DGMXYDQWH HW PpWDVWDWLTXHV
0 /HV pWXGHV FRQFHUQHQW HQ JpQpUDO XQIDLEOH QRPEUH (Q SUHPLqUH LQWHQWLRQ LO IDXW SURSRVHU OD UHFKHUFKH GX
GHSDWLHQWVQHSHUPHWWDQWSDVG·pWDEOLUGHVVWDQGDUGV JDQJOLRQVHQWLQHOOHTXLpYDOXHGHIDoRQDFFHSWDEOHj
(QFDVG·HQYDKLVVHPHQWJDQJOLRQQDLUHLQJXLQDOO·REMHFWLI
G·XQHFKLPLRWKpUDSLHQpRDGMXYDQWHHVWGHSHUPHWWUHXQH
UpGXFWLRQWXPRUDOHHWG·HQIDFLOLWHUO·H[pUqVH>@
Les plus anciens protocoles de chimiothérapie utilisaient
XQH DVVRFLDWLRQ GH OD EOpRP\FLQH YLQFULVWLQH HW PpWKRW-
UH[DWH>@'·DXWUHVpWXGHVUpWURVSHFWLYHVRQWUHFHQVpGLYHUV
SURWRFROHV GH FKLPLRWKpUDSLH ÁXRURXUDFLO FLVSODWLQH
GHIDX[QpJDWLIOHVWDWXWJDQJOLRQQDLUHPLFURVFRSLTXHSRXU
XQHPRUELGLWpPRLQVpOHYpHTXHODO\PSKDGpQHFWRPLHPRGL-
ÀpHELODWpUDOH>@&HWWHSURFpGXUHGRLWrWUHUpDOLVpH
VLPXOWDQpPHQW j OD FKLUXUJLH SpQLHQQH (OOH QH SHXW rWUH
UpDOLVpH GDQV XQ GHX[LqPH WHPSV TXH VL OD WXPHXU LQLWLD-
OHPHQWVXVSHFWpHGHULVTXHIDLEOHHVWÀQDOHPHQWGHULVTXH
LQWHUPpGLDLUHRXpOHYp>@
WD[DQHEOpRP\FLQH²FLVSODWLQH²PpWKRWUH[DWHQHSHUPHWWDQW • &KH]OHVSDWLHQWVjIDLEOHULVTXH7LV7D*HW7D*HW
DXFXQHFRQFOXVLRQ>@'HIDoRQSOXVUpFHQWH3L]]RFDUR F1XQHVXUYHLOODQFHHVWUHFRPPDQGpHFKH]XQSDWLHQW
HWDORQWWUDLWpTXHOTXHVSDWLHQWVDYHFXQHFKLPLRWKpUDSLH ELHQLQIRUPpHWFRPSOLDQWjODVXUYHLOODQFH
QpRDGMXYDQWHGHW\SH73)SDFOLWD[HOFLVSODWLQHHWÁXR- • &KH]OHVSDWLHQWVjULVTXHLQWHUPpGLDLUHRXpOHYp≥S7E
URXUDFLOSRXUXQHWXPHXULQH[WLUSDEOHRXSRXUXQHUpFLGLYH HWRX≥JUDGHHWF1XQHVWDGLÀFDWLRQJDQJOLRQQDLUH
JDQJOLRQQDLUH>@/DPRLWLpGHVSDWLHQWVpWDLHQWYLYDQWVVDQV LQYDVLYHHVWUHFRPPDQGpHDYHFDQDO\VHH[WHPSRUDQpH
UpFLGLYHjSOXVGHPRLV8QHpWXGHGHSKDVH,,DpYDOXp JDQJOLRQVHQWLQHOOHHQSULRULWpHWFXUDJHPRGLÀpELODWpUDO
O·LQWpUrWG·XQHFKLPLRWKpUDSLHQpRDGMXYDQWHDYHFF\FOHV VLQRQSOXVPRUELGH
GH7,3WD[ROLIRVIDPLGHHWFLVSODWLQHSRXUOHVSDWLHQWVD\DQW
XQHWXPHXUGXSpQLVDYHFHQYDKLVVHPHQWJDQJOLRQQDLUHGH
VWDGHV 1 RX 1 HW 0 >@ 3DUPL OHV  SDWLHQWV LQFOXV
GDQVO·pWXGHODPRLWLpDREWHQXXQHUpSRQVHREMHFWLYHHW
SDWLHQWVpWDLHQWHQUpSRQVHFRPSOqWH$YHFXQVXLYLPpGLDQ
GHPRLVGHVSDWLHQWVpWDLHQWYLYDQWVVDQVUpFLGLYH
/·pWXGH$)8*(78*B0(*$&(31&7DTXDQW
jHOOHFKRLVLG·XWLOLVHUXQHDVVRFLDWLRQWD[ROLIRVIDPLGHHW
FLVSODWLQH>@
/HVSUHPLqUHVpWXGHVG·HIÀFDFLWpGHODFKLPLRWKpUDSLH
• 'DQVOHVWXPHXUVjKDXWULVTXHVLOHJDQJOLRQVHQWLQHOOH
QHÀ[HTXHG·XQF{WpXQGHX[LqPHHVVDLHVWSRVVLEOH
DYDQWXQFXUDJHPRGLÀpVLO·H[DPHQQ·HVWWRXMRXUVSDV
FRQWULEXWLI>@
• (Q FDV GH JDQJOLRQ VHQWLQHOOH RX GH FXUDJH PRGLÀp
QpJDWLIVXQHVXUYHLOODQFHHVWUHFRPPDQGpH
• (QFDVGHJDQJOLRQVHQWLQHOOHRXGHFXUDJHPRGLÀpSRVLWLIV
une lymphadénectomie inguinale totale est recomman-
GpHGXF{WpFRQFHUQpODO\PSKDGpQHFWRPLHVXSHUÀFLHOOH
PRGLÀpHFRQWURODWpUDOHQ·HVWSDVV\VWpPDWLTXHO·DQDO\VH
DGMXYDQWHGDQVOHFDQFHUGXSpQLVRQWpYDOXpGHQRPEUHXVHV QpJDWLYHGXJDQJOLRQVHQWLQHOOHHVWVXIÀVDQWH
S272 3+6DYRLHHWDO

≤ pT1aG1 Surveillance
Négative Surveillance

cNO Refaire ganglion

Non contributif sentinelle
bilatéral ou
Curage
modifié bilatéral

Ganglion
≥ pT1bG2
sentinelle Refaire ganglion
sentinelle
Non contributif
ou
unilatéral
Curage
modifié côté muet

Curage inguinal
complet côté pN+

(pas de curage côté

pN0+++)

Positif

GETUG 25

)LJXUH$OJRULWKPHGpFLVLRQQHOF1

6WDGHF1F1DGpQRSDWKLHPRELOHXQLTXH Une prise en charge multimodale est recommandée,

RXPXOWLSOH)LJXUH GX IDLW GX SURQRVWLF SpMRUDWLI 8QH FKLPLRWKpUDSLH QpR
DGMXYDQWHHVWFRQVHLOOpHVXLYLHG·XQFXUDJHUDGLFDOFKH]OHV
8QHDQWLELRWKpUDSLHQHGRLWSDVUHWDUGHUGDQJHUHXVHPHQW UpSRQGHXUV>@'DQVOHVDXWUHVVLWXDWLRQVVWDELOLVDWLRQ
O·H[SORUDWLRQFKLUXUJLFDOH RX SURJUHVVLRQ VHXOH XQH SULVH HQ FKDUJH SDOOLDWLYH HVW
8QH F\WRSRQFWLRQ j O·DLJXLOOH ÀQH HVW XQH RSWLRQ PDLV licite : chimiothérapie de rattrapage ou radiothérapie et
Q·HVW FRQWULEXWLYH TXH VL HOOH HVW SRVLWLYH (OOH SHUPHW VRLQVGHVXSSRUW
alors de réaliser un curage inguinal complet homolatéral &KH]OHVSDWLHQWVORFDOHPHQWDYDQFpVQRQRSpUDEOHVXQH
G·HPEOpH VDQV SDVVHU SDU OH FXUDJH LQJXLQDO PRGLÀp RX FKLPLRWKpUDSLHGRLWrWUHFRQVLGpUpHHWHQFDVGHVWDELOLWpRX
G·LQFOXUHOHSDWLHQWGDQVO·pWXGH$)8*(78*B0(*$&(3 UpSRQVHGHODPDODGLHO·LQFOXVLRQGDQVOHSURWRFROH38/6(
1&7>@ GRLWrWUHFRQVLGpUpH>@
(Q O·DEVHQFH GH FRQILUPDWLRQ DQDWRPRSDWKRORJLTXH
F\WRSRQFWLRQQpJDWLYHRXQRQUpDOLVpHXQHH[pUqVHFKLUXU-
JLFDOHGHVJDQJOLRQVSDOSDEOHVDYHFHQYRLHQH[WHPSRUDQpH
HVW UHFRPPDQGpH HW VL O·HQYDKLVVHPHQW HVW FRQÀUPp OD
O\PSKDGpQHFWRPLHLQJXLQDOHWRWDOHHVWUpDOLVpHGDQVOHPrPH
WHPSV
6WDGHVSRVWRSpUDWRLUHVS1
• 'DQVOHVVWDGHVS1XQHVXUYHLOODQFHHVWUHFRPPDQGpH
XQWUDLWHPHQWDGMXYDQWQHSHXWrWUHUHWHQXTXHGDQVOH
/DUDGLRWKpUDSLHQpRDGMXYDQWHQ·HVWSDVUHFRPPDQGpH FDGUHG·HVVDLFOLQLTXH
8QHO\PSKDGpQHFWRPLHSHOYLHQQHVLPXOWDQpHHVWQpFHV- • 8QH O\PSKDGpQHFWRPLH SHOYLHQQH KRPRODWpUDOH HVW
VDLUHVLXQHDGpQRSDWKLHLOLDTXHVXVSHFWHHVWUHSpUpHDXELODQ UHFRPPDQGpH VL FH JDQJOLRQ XQLTXH HVW HQ UXSWXUH
G·H[WHQVLRQSUpRSpUDWRLUH FDSVXODLUHLOQHV·DJLWSOXVG·XQS1
• 'DQV OHV S1 XQLODWpUDX[ XQH O\PSKDGpQHFWRPLH SHO-
YLHQQH KRPRODWpUDOH SUpFRFH HVW UHFRPPDQGpH DYDQW
6WDGHF1)LJXUH XQHFKLPLRWKpUDSLHDGMXYDQWHVXUWRXWV·LO\DRXSOXV
ganglions atteints, effraction capsulaire ou un ganglion
/DF\WRSRQFWLRQHWODELRSVLHQHVRQWSDVLQGLVSHQVDEOHV GHSOXVGHFP
8Q ELODQ G·H[WHQVLRQ SDU ))'* 3(7VFDQQHU RX SDU • 'DQVOHVVWDGHVS1S1XQHFKLPLRWKpUDSLHDGMXYDQWH
VFDQQHUWKRUDFRDEGRPLQRSHOYLHQHVWUHFRPPDQGp>@ DX[O\PSKDGpQHFWRPLHVHVWUHFRPPDQGpH
 )UHQFKFF$)8JXLGHOLQHVîXSGDWHSHQLOHFDQFHU
LDN inguinale totale pN1 Surveillance
côté pN+
+ GS (ou curage
modifié) LDN pelvienne
controlatérale pN2/pN3 ipsilatérale au pN+
Positive + chimiothérapie
adjuvante
GETUG 25
Cytoponction
cN1
option
et cN2
conseillée LDN totale côté N+
Exérèse ganglionnaire Positive ± Curage pelvien
(analyse extemporanée) ipsilatéral si > 2N+ ou EEC
Négative
+ GS (ou curage modifié)
controlatérale
Négative Surveillance
PetTDM
FDG
cN+
(sinon
TDM TAP) Exérèse ganglionnaire LDN totale côté N+
Négative (analyse extemporanée) Positive ± Curage pelvien
+ GS (ou curage modifié) ipsilatéral si > 2N+ ou EEC
controlatérale
Cytoponction
cN3
option LDN inguinale totale
inguinal
conseillée Répondeurs côté N+
GETUG 25 LDN modifiée côté N0
Positive
Si non incluable : Traitements palliatifs
Chimiothérapie Progression (y compris chirurgie
néo-adjuvante ou radiothérapie)

Stabilité
PULSE
si stable ou en réponse

Si inopérable
AcSé Nivolumab
Chimiothérapie si résistants ou
réfractaires
LDN inguinale et Radiothérapie ou
cN3 pelvienne Chimiothérapie adjuvante
pelvien et GS controlatérale (sauf si chimioth.
± chimioth.néo-adjuvante néo-adjuvante) Si contre-indication Traitements palliatifs
chimiothérapie dont chirurgie

Figure 3. $OJRULWKPHGpFLVLRQQHOF1F1F1F1

S273
/pJHQGH/'1 O\PSKDGpQHFWRPLH*6 JDQJOLRQVHQWLQHOOH((& HIIUDFWLRQH[WUDFDSVXODLUH
S274 3+6DYRLHHWDO

/D UDGLRWKpUDSLH DGMXYDQWH HVW HQYLVDJHDEOH PDLV SHX GH 7DEOHDXGHUHFRPPDQGDWLRQRecommandations

GRQQpHVVRQWGLVSRQLEOHVSRXUODUHFRPPDQGHU de la SULVHHQFKDUJHJDQJOLRQQDLUHHWPpWDVWDWLTXH
/DO\PSKDGpQHFWRPLHLOLDTXHSUpFRFHHVWUHFRPPDQGpH
VLDXPRLQVJDQJOLRQVLQJXLQDX[VRQWPpWDVWDWLTXHVRXVL Statut Prise en charge Grade
une effraction capsulaire ganglionnaire inguinale est mise F1 7LV7D*7*VXUYHLOODQFH Fort
HQpYLGHQFHVXUXQGHVJDQJOLRQV(OOHGRLWrWUHVLPXOWDQpH
VLHOOHHVWLQGLTXpHGqVO·DQDO\VHH[WHPSRUDQpH6LFHVRQW ≥7E*JDQJOLRQVHQWLQHOOH Fort
OHVUpVXOWDWVGpÀQLWLIVTXLO·LQGLTXHQWHOOHVHUDGLIIpUpHVDQV *6RXFXUDJHLQJXLQDO
GpODLVDXIVLOHSDWLHQWHVWLQFOXVGDQVO·pWXGH$)8*(78* PRGLÀpELODWpUDOVL*6
B0(*$&(31&7>@ LQGLVSRQLEOHRXFRQWURODWpUDOVL
*6XQLODWpUDOjGHX[UHSULVHV

Traitement des stades métastatiques F1F1 ([pUqVHFKLUXUJLFDOH*6 Fort

controlatéral (analyse
extemporanée ± curage
Chimiothérapie palliative LQJXLQDOFRPSOHWVLS1
pN+ &XUDJHLQJXLQDOUDGLFDOF{Wp Fort
(QSKDVHPpWDVWDWLTXHOHVPrPHVSURWRFROHVRQWpWppYDOXpV (cytoponction S1HWH[SORUDWLRQLQYDVLYH
HQSKDVH,,TXHFHX[XWLOLVpVHQVLWXDWLRQSpULRSpUDWRLUHDYHF ou sur examen FRQWURODWpUDOH*6RXFXUDJH
OH%03>@OH7,3>@RXOH73)>@/HVWDX[GHUpSRQVHV H[WHPSRUDQp PRGLÀp
YDULHQW GH  j  DYHF GHV VXUYLHV VDQV SURJUHVVLRQ
PRGHVWHVGHTXHOTXHVPRLV/HVWR[LFLWpVVHPEOHQWLPSRU- cN3 inguinal &KLPLRWKpUDSLHQpRDGMXYDQWH Faible
WDQWHVSRXUOHSURWRFROH%03/HVSURSRVLWLRQVHQSUHPLqUH et curage radical si répondeur
OLJQHSHXYHQWrWUHOH73)RXOH7,3>@$XFXQWUDLWHPHQW
cN3 pelvien &XUDJHLQJXLQDOHWSHOYLHQ Fort
Q·D pWp GpÀQL HQ VHFRQGH OLJQH OHV PRQRWKpUDSLHV SDU
(± chimiothérapie néo-
FLVSODWLQH HW SDFOLWD[HO RQW XQH DFWLYLWp PRGHVWH >@ ,O
DGMXYDQWHH[SORUDWLRQ
IDXW SULYLOpJLHU SRXU FHV PDODGHV OHV LQFOXVLRQV GDQV OHV
sanglante controlatérale
HVVDLVWKpUDSHXWLTXHV
Aucun produit de chimiothérapie n’a l’autorisation de mise pN1 6XUYHLOODQFHSDVGHFXUDJH Fort
VXUOHPDUFKpSRXUVRQXWLOLVDWLRQGDQVOHFDQFHUGXSpQLV SHOYLHQ
S1S1RX &XUDJHSHOYLHQKRPRODWpUDO Fort
Immunothérapie adénopathies
pelviennes
/·LPPXQRWKpUDSLHQ·DSDVHQFRUHSURXYpVRQHIÀFDFLWpGDQV suspectes
OHFDQFHUGXSpQLVHWQHSHXWrWUHXWLOLVpHHQGHKRUVG·XQ à l’imagerie
HVVDLWKpUDSHXWLTXH
S1S1 'LVFXWHUXQHFKLPLRWKpUDSLH Fort
Ces tumeurs expriment programmed death-ligand 1
DGMXYDQWH
3'/VXUOHVFHOOXOHVLQÀOWUDQWHVHQWUHHWDYHFXQ
SURQRVWLFSOXVSpMRUDWLIHQWHUPHVGHVXUYLH>@ Tous N Radiothérapie non Fort
4XHOTXHV pWXGHV GH SKDVH ,, VRQW HQ FRXUV GDQV OHV recommandée (sauf rares
WXPHXUV GX SpQLV PpWDVWDWLTXHV DVVRFLDQW VRLW GHV FRP- VLWXDWLRQVSDOOLDWLYHV
ERV LPPXQRWKpUDSLH HVVDLV LSLOLPXPDE ² QLYROXPDE 
1&7 1&7 VRLW HQ PRQRWKpUDSLH M+ &KLPLRWKpUDSLHSDOOLDWLYH Faible
FRPPHDYHFOHSHPEUROL]XPDE1&7O·DYpOXPDE RXHVVDLVWKpUDSHXWLTXHV
1&7O·DWH]ROL]XPDE1&7HWOHQLYR-
OXPDEHQWUDLWHPHQWGHVHFRQGHOLJQHSURJUDPPH$F6pHQ
)UDQFH1&7>@
8QDXWUHHVVDLHQ)UDQFHpYDOXHO·LQWpUrWGHO·LPPXQR- Traitement des récidives
WKpUDSLH SDU DYpOXPDE HQ PDLQWHQDQFH DSUqV O·REWHQWLRQ
G·XQH UpSRQVH DSUqV OD FKLPLRWKpUDSLH pWXGH 38/6(
1&7 FRPPH FH TXL D pWp UpDOLVp GDQV O·pWXGH Récidives locales
-DYHOLQ%ODGGHU>@'·DXWUHVDVVRFLDWLRQVVRQWpYDOXpHV
DYHF GHV WKpUDSHXWLTXHV FLEOpHV FRPPH OH FDER]DQWLQLE /HWDX[GHUpFLGLYHORFDOHDSUqVXQHFKLUXUJLHFRQVHUYDWULFH
HW O·DVVRFLDWLRQ LSLOLPXPDE HW QLYROXPDE 1&7
dans un programme pour les tumeurs rares comprenant les
WXPHXUVGXSpQLV
'·DXWUHV YRLHV VRQW HQ FRXUV G·H[SORUDWLRQ SRXU FHX[
LQIHFWpV SDU +39 SDU GHV pWXGHV GH YDFFLQDWLRQV RX
GHV DVVRFLDWLRQV FRPPH DWp]ROL]XPDE HW EHYDFL]XPDE
HVWGHjTXHOTXHVRLWOHWUDLWHPHQWUpDOLVp>@
(OOH VXUYLHQW VXUWRXW GDQV OHV  SUHPLqUHV DQQpHV HW HVW
FRUUpOpHDX[PDUJHVFKLUXUJLFDOHVSRVLWLYHV(QFDVGHJHVWH
FRQVHUYDWHXU LQLWLDO XQH UHSULVH SDU XQ JHVWH FRQVHUYD-
WHXU GRLW rWUH SUpIpUpH V·LO HVW SRVVLEOH >@ (Q FDV
d’atteinte profonde, une amputation partielle ou totale
1&7 HVWUHFRPPDQGpH
)UHQFKFF$)8JXLGHOLQHVîXSGDWHSHQLOHFDQFHU
Récidives ganglionnaires
(QFDVGHUpFLGLYHLQJXLQDOHXQHO\PSKDGpQHFWRPLHLQJXL-
QDOHFRPSOqWHGRLWrWUHSURSRVpHVLHOOHQ·DSDVpWpUpDOLVpH
'DQVOHFDVFRQWUDLUHXQHFKLPLRWKpUDSLHHWXQHUDGLRWKp-
UDSLHGHUDWWUDSDJHGRLYHQWrWUHGLVFXWpHVFDUOHGUDLQDJH
O\PSKDWLTXHSRVWRSpUDWRLUHHVWPRGLÀpHWOHWDX[GHVXUYLH
DSUqV UpFLGLYH JDQJOLRQQDLUH DSUqV JDQJOLRQ VHQWLQHOOH RX
O\PSKDGpQHFWRPLHPRGLÀpHHVWGHjDQV>@
Résultats
S275
3RXUXQSDWLHQWF1DYHFXQS7OHJUDGHSHUPHWWUD
GHSURSRVHUXQHVXUYHLOODQFHHWXQJUDGHRXLPSRVHUDXQ
FXUDJHLQJXLQDO>@PrPHVLXQHpWXGHUHWURXYHXQJDQJOLRQ
VHQWLQHOOH HQYDKL GDQV  GHV7* >@ FH TXL SRXVVH-
UDLW j UpDOLVHU V\VWpPDWLTXHPHQW XQH H[pUqVH GX JDQJOLRQ
VHQWLQHOOH/HVWXPHXUVGHJUDGHpOHYpLPSRVHQWXQJHVWH
FKLUXUJLFDOSUXGHQWHQFDVG·DSSURFKHFRQVHUYDWULFHDÀQGH
JDUDQWLUGHVPDUJHVQpJDWLYHV$LQVLFHUWDLQVRQWSXSUpIpUHU
XQHDPSXWDWLRQSDUWLHOOHjXQHFKLUXUJLHFRQVHUYDWULFH>@
Selon le type histologique
&HUWDLQVW\SHVGHFDUFLQRPHVEDVDORwGHVYHUUXFREDVDORwGHV
Résultats carcinologiques
Selon le stade local
/DVXUYLHVSpFLÀTXHjDQVHVWGHSRXUOH&,6
SRXUOHVS7HWSRXUOHVS7>@
3RXUOHVOpVLRQV7OHWDX[GHUpFLGLYHHVWGHj
HWOHWDX[GHPRUWDOLWpVSpFLÀTXHGHjjDQV>@
/HWUDLWHPHQWSDU)8SRXUXQ&,6GRQQHGHUpSRQVHV
VDUFRPDWRwGHVSVHXGRJODQGXODLUHVPXFRpSLGHUPRwGHV«
RXOHVFDUFLQRPHVjFHOOXOHVFODLUHVVRQWGHVFDUFLQRPHVWUqV
DJUHVVLIVTXLGRLYHQWIDLUHGLVFXWHUXQHSULVHHQFKDUJHSOXV
DJUHVVLYHTXHOVTXHVRLHQWOHVWDGHHWOHJUDGHSpQHFWRPLH
SDUWLHOOHODUJH“FXUDJHLQJXLQDOELODWpUDO>@
Résultats fonctionnels
FRPSOqWHVHWSDUPLFHVUpSRQVHVFRPSOqWHVGHUpFLGLYHV /DFKLUXUJLHFRQVHUYDWULFHORUVTX·HOOHHVWSRVVLEOHGRQQH
SUpFRFHVWHPSVPR\HQORUVGHODUpFLGLYH PRLV>@
/HWUDLWHPHQWSDUODVHUGHVWXPHXUV&,6HWS7DXQWDX[
GHUpFLGLYHjDQVYDULDQWGHjFHTXLQpFHVVLWH
XQHFKLUXUJLHFRPSOpPHQWDLUH>@/DVXUYLHVSpFLÀTXH
jDQVHVWVXSpULHXUHj>@
/DFKLUXUJLHFRQVHUYDWULFH©UHVXUIDoDJHªRXJODQGXOHF-
GHELHQPHLOOHXUVUpVXOWDWVFRQFHUQDQWOHVRUJDVPHVO·LPDJH
GHVRLODTXDOLWpGHYLHHWOHVPLFWLRQVTXHOHVDPSXWDWLRQV
vsp>@
Statut mictionnel
WRPLH D XQ WDX[ GH UpFLGLYH VXLYLH GH  j  DQV GH  j
DYHFXQHPRUWDOLWpVSpFLÀTXHQXOOH>@/HVUpFLGLYHV
SUpFRFHVVXUYLHQQHQWGDQVGHVFDVGDQVOHVDQV2Q
UHWURXYHGHVIDFWHXUVSUpGLFWLIVGHUpFLGLYHHQYDKLVVHPHQW
SpULQHUYHX[&,6PDUJHSRVLWLYHHWKDXWJUDGHORUVTXHOHV
VRQWSUpVHQWVOHULVTXHHVWPXOWLSOLpSDU>@
/DFKLUXUJLHQRQFRQVHUYDWULFHDPSXWDWLRQSDUWLHOOHRX
/HVWDWXWPLFWLRQQHOHVWHQJpQpUDOERQSRXUOHVFKLUXUJLHV
FRQVHUYDWULFHVDYHFGHUDUHVFDVGHVWpQRVHPpDWLTXHPDLV
OHVGLIÀFXOWpVPLFWLRQQHOOHVGHVSDWLHQWVD\DQWHXXQHDPSX-
tation partielle sont sans doute sous-estimées car rarement
pYDOXpHV
/DFXULHWKpUDSLHHQWUDvQHXQHVWpQRVHGXPpDWTXLSHXW
WRWDOHDXQWDX[GHUpFLGLYHORFDOHGHj>@ rWUHFRPSOH[HjWUDLWHUGDQVSOXVGHGHVFDV>@
$SUqV FXULHWKpUDSLH OH WDX[ GH UpFLGLYH YDULH GH  j
DYHFGHVWpQRVHXUpWUDOH>@
Sexualité

Selon le stade ganglionnaire ,OIDXWUHODWLYLVHUOHVUpVXOWDWVIRQFWLRQQHOVGHVpWXGHVTXL

Q·RQWSDVXWLOLVpGHTXHVWLRQQDLUHVYDOLGpVSRXUODVH[XDOLWp
3RXUOHVSDWLHQWVS1ODVXUYLHVSpFLÀTXHjDQVYDULHGH DSUqVWUDLWHPHQWG·XQHWXPHXUGXSpQLV
j>@
3RXUOHVSDWLHQWVS1ODVXUYLHVSpFLÀTXHjDQVYDULH
GH>@j>@
/DVXUYLHVSpFLÀTXHjDQVSRXUXQS1HVWGHj
HWSRXUXQS1GHj>@8QIDFWHXUSURQRVWLTXH
HVWDSSDUXHQHWVHPEOHSHUWLQHQWOHSRXUFHQWDJHGH
$SUqV ODVHU LO Q·\ D SDV GH G\VIRQFWLRQ pUHFWLOH '(
PDLVGHVGLIÀFXOWpVjSUDWLTXHUFHUWDLQHVDFWLYLWpVVH[XHOOHV
jFDXVHGHGRXOHXUVUpVLGXHOOHV>@
(QFDVGH©UHVXUIDoDJHªXQHpWXGHSURVSHFWLYHUpFHQWH
PRQWUHXQHDPpOLRUDWLRQGHODYLHVH[XHOOHFKH] GHV
SDWLHQWVHWXQDVSHFWFRVPpWLTXHVDWLVIDLVDQWVXUXQH
JDQJOLRQVHQYDKLVORUVGXFXUDJHLQJXLQDOUDGLFDOVL
GHJDQJOLRQVVRQWHQYDKLVODVXUYLHVSpFLÀTXHHVWGH
DORUVTXHVLSOXVGHGHVJDQJOLRQVSUpOHYpVVRQWHQYDKLV
HOOHHVWVHXOHPHQWGH>@3RXUFRPSDUDLVRQHQFDV
GHWXPHXU0ODVXUYLHVSpFLÀTXHjDQVHVWGH
Selon le grade tumoral
Le grade tumoral pourra faire changer d’attitude
WKpUDSHXWLTXH  VL SpQHFWRPLH SDUWLHOOH GH PrPH TXH OD FRQÀDQFH
pFKHOOHYLVXHOOHFRVPpWLTXH>@
(QFDVGHJODQGXOHFWRPLHLOHVWGpFULWHQWUHHWGH
PRGLÀFDWLRQGHODVH[XDOLWp
$SUqVDPSXWDWLRQSDUWLHOOHRQUHWURXYHXQHGpJUDGDWLRQGH
ODVH[XDOLWpFKH]PrPHVLOHVpUHFWLRQVVRQWSUpVHQWHVGDQV
GHVFDVHWOHVRUJDVPHVFRQVHUYpVGDQVGHVFDV>@
8QHpWXGHPXOWLFHQWULTXHFRPSDUDQWODVH[XDOLWpDSUqV
FKLUXUJLHFRQVHUYDWULFHHWDSUqVSpQHFWRPLHSDUWLHOOHUHWURXYH
des différences importantes en termes de satisfaction par
UDSSRUW j O·DSSDUHQFH   VL FKLUXUJLH FRQVHUYDWULFH vs
S276 3+6DYRLHHWDO

HQ VD VH[XDOLWp SDVVH GH  j  HQ FDV GH SpQHFWRPLH • après glandulectomie totale, amputation partielle ou
SDUWLHOOHHWGHVUpVXOWDWVLGHQWLTXHVVRQWUHWURXYpVFKH]OHV totale :
SDUWHQDLUHV>@ Ⱦ pendant 2 ans : consultation tous les 3 mois,
Ⱦ au-delà de 2 ans et jusqu’à 5 ans :FRQVXOWDWLRQWRXVOHVDQV

6XLYL7DEOHDX[HW
6XLYLORFRUpJLRQDOLQJXLQDO

6XLYLORFDOGXSpQLVDQVPLQLPXP 'DQVWRXVOHVFDVO·DSSUHQWLVVDJHGHVDXWRSDOSDWLRQVLQJXL-

'DQVWRXVOHVFDVO·DSSUHQWLVVDJHGHVDXWRH[DPHQVUpJXOLHUV
est recommandé :
• après traitement local non chirurgical : autoexamen
UpJXOLHUHWVXLYLFOLQLTXH Ⱦ au-delà de 2 ans et jusqu’à 5 ans : consultation tous
Ⱦ pendant 2 ansFRQVXOWDWLRQWRXVOHVPRLVDYHFELRSVLH
DXPRLQGUHGRXWH$XPRLQVXQHELRSVLHjWLWUHV\VWp-
PDWLTXH GDQV OHV  DQV SRXU SUHXYH KLVWRORJLTXH GH
O·pUDGLFDWLRQVXUOD]RQHWUDLWpHDSUqVODVHUWRSLTXHRX
nales régulières est recommandé :
• sans curage initial : autopalpation régulière et examen
FOLQLTXH
Ⱦ pendant 2 ans : consultation tous les 3 mois,
les 6 mois ;
• DSUqVFXUDJHLQLWLDOS1RX*6QpJDWLIDXWRSDOSDWLRQHW
H[DPHQFOLQLTXH
Ⱦ pendant 2 ans : consultation tous les 3 mois (± cytoponc-
tion semestrielle sous échographie),
SKRWRWKpUDSLHG\QDPLTXHHW Ⱦ au-delà de 2 ans et jusqu’à 5 ans : consultation tous
Ⱦ au-delà de 2 ans et jusqu’à 5 ans : consultation tous les ans ;
les 6 mois ; • DSUqVFXUDJHLQLWLDOS1DXWRSDOSDWLRQHWH[DPHQFOL-
• DSUqVWUDLWHPHQWORFDOFKLUXUJLFDOFRQVHUYDWHXUELRSVLH QLTXH V\VWpPDWLTXH )'* 3(77'0 ,50 HW VFDQQHU 
exérèse, glandulectomie partielle ou resurfaçage) : XWLOLVDWLRQHWU\WKPHjGLVFXWHUDXFDVSDUFDVHQ5&3
DXWRH[DPHQUpJXOLHUHWVXLYLFOLQLTXH Ⱦ pendant 2 ans : consultation tous les 3 mois (± cytoponc-
Ⱦ pendant 2 ans : consultation tous les 3 mois, tion semestrielle sous échographie),
Ⱦ au-delà de 2 ans et jusqu’à 5 ans : consultation tous Ⱦ au-delà de 2 ans et jusqu’à 5 ans : consultation tous
les 6 mois ; OHVPRLV

Tableau 3. 6XLYLORFDOGXSpQLVDSUqVGLIIpUHQWVW\SHVGHWUDLWHPHQWVELRSVLHDXPRLQGUHGRXWHSDULQVSHFWLRQ

RXSDOSDWLRQ>@
Modalité M1 M3 M6 M9 0 M15 M18 0 0 0 M36 0 M48 M54 0
Traitement local non chirurgical
Apprentissage
de l’autoexamen
régulier
([DPHQFOLQLTXH

Biopsie Au moindre doute et

DXPRLQVXQHELRSVLHQpJDWLYHGDQVOHVGHX[DQVsi CIS
7UDLWHPHQWORFDOFKLUXUJLFDOELRSVLHH[pUqVHJODQGXOHFWRPLHSDUWLHOOHRXUHVXUIDoDJH
Apprentissage
de l’autoexamen
régulier
([DPHQFOLQLTXH
Traitement après glandulectomie partielle, amputation partielle ou totale
Apprentissage
de l’autoexamen
régulier
([DPHQFOLQLTXH
)UHQFKFF$)8JXLGHOLQHVîXSGDWHSHQLOHFDQFHU S277

Tableau 4. 6XLYLORFRUpJLRQDOGHVDLUHVJDQJOLRQQDLUHVHQIRQFWLRQGHODSULVHHQFKDUJHLQLWLDOH>@
Modalité M1 M3 M6 M9 0 M15 M18 0 0 0 M36 0 M48 M54 0
Sans curage initial
Apprentissage
autopalpation
régulière
([DPHQFOLQLTXH
$SUqVFXUDJHLQLWLDOS1RX*6QpJDWLI
Apprentissage
autopalpation
régulière
([DPHQFOLQLTXH
Cytoponction
sous échographie
optionnelle
$SUqVFXUDJHLQLWLDOSRVLWLIS1
Apprentissage
autopalpation
régulière
([DPHQFOLQLTXH
Cytoponction
sous échographie
optionnelle
Imagerie )'*7(37'0,50HWVFDQQHU7$3XWLOLVDWLRQHWU\WKPHjGpÀQLUDXFDVSDUFDVHQ5&3

Déclaration de liens d’intérêts >@ %R]]LQL*3URYHQ]DQR05RPHUR2WHUR-0DUJUHLWHU0*DUFLD

&UX](2VPRORUVNLM%HWDO5ROHRI3HQLOH'RSSOHU86LQWKH
3UHRSHUDWLYH$VVHVVPHQWRI3HQLOH6TXDPRXV&HOO&DUFLQRPD
3+6DYRLH2UDWHXUHWFRQVXOWDQWSRXUOH&&$)8RQOLQH
3DWLHQWV 5HVXOWV )URP D /DUJH 3URVSHFWLYH 0XOWLFHQWHU
$)8 &RQVXOWDQW SRXU %06 PHPEUH G·XQ VRXVFRPLWp (XURSHDQ6WXG\8URORJ\
-DQVVHQ H[SHUW XURORJXH &RLQYHVWLJDWHXU  1RYDUWLV >@ .ULVKQD 6 6KDQEKRJXH . 6FKLHGD 1 0RUEHFN ) +DGDV %
-DQVVHQ&LODJ,QWHUYHQWLRQDX[-280&&$)8/HVDXWUHV .XONDUQL * HW DO 5ROH RI 05, LQ 6WDJLQJ RI 3HQLOH &DQFHU
DXWHXUVGpFODUHQWQHSDVDYRLUGHOLHQVG·LQWpUrWV -0DJQ5HVRQ,PDJLQJ
>@ +DQFKDQDOH9<HR/6XEHGL16PLWK-:DK7+DUQGHQ3
HW DO 7KH DFFXUDF\ RI PDJQHWLF UHVRQDQFH LPDJLQJ 05,
Références LQ SUHGLFWLQJ WKH LQYDVLRQ RI WKH WXQLFD DOEXJLQHD DQG WKH
XUHWKUDGXULQJWKHSULPDU\VWDJLQJRISHQLOHFDQFHU%-8,QW
>@ 'DXELVVH0DUOLDF / &RORQQD 0 7UHWDUUH % 'HIRVVH] * 
0ROLQLH ) -HKDQQLQ/LJLHU . HW DO /RQJWHUP WUHQGV LQ >@ 9HOD]TXH] () %DUUHWR -( 5RGULJXH] , 3LULV$ &XELOOD$/
LQFLGHQFH DQG VXUYLYDO RI SHQLOH FDQFHU LQ )UDQFH &DQFHU /LPLWDWLRQV LQ WKH LQWHUSUHWDWLRQ RI ELRSVLHV LQ SDWLHQWV
(SLGHPLRO3W$ ZLWK SHQLOH VTXDPRXV FHOO FDUFLQRPD ,QW - 6XUJ 3DWKRO
>@ /HEHOR5/%RXOHW*1NRVL&0%LGD01%RJHUV-30SKDKOHOH 
0- 'LYHUVLW\ RI +39 W\SHV LQ FDQFHURXV DQG SUHFDQFHURXV >@ 9HOD]TXH]()&XELOOD$//LFKHQVFOHURVXVLQSDWLHQWVZLWK
penile lesions of South African men: implications for future VTXDPRXVFHOOFDUFLQRPDRIWKHSHQLVIUHTXHQWDW\SLDVDQG
+39YDFFLQDWLRQVWUDWHJLHV-0HG9LURO FRUUHODWLRQZLWKVSHFLDOFDUFLQRPDYDULDQWVVXJJHVWVDSUHFDQ-
>@ +DNHQEHUJ2:&RPSHUDW(00LQKDV61HFFKL$3URW]HO& FHURXVUROH$P-6XUJ3DWKRO
:DWNLQ1($8JXLGHOLQHVRQSHQLOHFDQFHUXSGDWH(XU >@ 7HLFKPDQ-06HD-7KRPSVRQ,0(OVWRQ'01RQLQIHFWLRXV
8URO
>@ 5HFRPPDQGDWLRQYDFFLQDOHYDFFLQDWLRQFRQWUHOHVSDSLOORPD-
YLUXVFKH]OHVJDUoRQV,Q+$6HGLWRU3DULV
>@ /LHEORQJ %- 0RQWJRPHU\ %(( 6X /- 1DNDJDZD 0 1DWXUDO
KLVWRU\ RI KXPDQ SDSLOORPDYLUXV DQG YDFFLQDWLRQV LQ PHQ
SHQLOHOHVLRQV$P)DP3K\VLFLDQ
>@ 5HQDXG9LOPHU&&DYHOLHU%DOOR\%9HUROD20RUHO36HUYDQW
-0'HVJUDQGFKDPSV)HWDO$QDO\VLVRIDOWHUDWLRQVDGMDFHQW
WR LQYDVLYH VTXDPRXV FHOO FDUFLQRPD RI WKH SHQLV DQG WKHLU
UHODWLRQVKLSZLWKDVVRFLDWHGFDUFLQRPD-$P$FDG'HUPDWRO
$OLWHUDWXUHUHYLHZ+HDOWK6FL5HSH 
>@ %HUWRORWWR06HUDÀQL*'RJOLRWWL/*DQGROIR1*DQGROIR1* >@ %H]HUUD60&KDX[$%DOO0:)DUDM6)0XQDUL(*RQ]DOH]
%HOJUDQR0HWDO3ULPDU\DQGVHFRQGDU\PDOLJQDQFLHVRIWKH 5RLERQ 1 HW DO +XPDQ SDSLOORPDYLUXV LQIHFWLRQ DQG
SHQLVXOWUDVRXQGIHDWXUHV$EGRP,PDJLQJ
6 3+6DYRLHHWDO

LPPXQRKLVWRFKHPLFDO S,1.D H[SUHVVLRQ DV SUHGLFWRUV >@ 0DQMXQDWK$%UHQWRQ7:\OLH6&RUELVKOH\&0:DWNLQ1$

RIRXWFRPHLQSHQLOHVTXDPRXVFHOOFDUFLQRPDV+XP3DWKRO 7RSLFDO7KHUDS\IRUQRQLQYDVLYHSHQLOHFDQFHU7LVXSGDWHG
 UHVXOWVDQGWR[LFLW\7UDQVO$QGURO8URO
>@ $XPD\U.6XVDQL0+RUYDW5:UED)0D]DO3.ODWWH7HWDO >@ %UDFND $ *ODQV UHVHFWLRQ DQG SODVWLF UHSDLU %-8 ,QW
3,1.$ LPPXQRKLVWRFKHPLVWU\ IRU GHWHFWLRQ RI KXPDQ 
SDSLOORPDYLUXVDVVRFLDWHGSHQLOHVTXDPRXVFHOOFDUFLQRPDLV >@ *DUDIID*5DKHHP$$&KULVWRSKHU1$5DOSK'-7RWDOSKDOOLF
VXSHULRUWRLQVLWXK\EULGL]DWLRQ,QW-,PPXQRSDWKRO3KDUPDFRO UHFRQVWUXFWLRQDIWHUSHQLOHDPSXWDWLRQIRUFDUFLQRPD%-8,QW

>@ 0DQQZHLOHU66\JXOOD67V\EURYVN\\25D]PDUD<3XPPHU.
5HJDXHU6&OHDUFHOOGLIIHUHQWLDWLRQDQGO\PSKDWLFLQYDVLRQEXW
QRWWKHUHYLVHG710FODVVLÀFDWLRQSUHGLFWO\PSKQRGHPHWDVWDVHV
LQS7SHQLOHFDQFHUDFOLQLFRSDWKRORJLFVWXG\RISDWLHQWV

>@ +DNHQEHUJ2:0LQKDV61HFFKL$3URW]HO&:DWNLQ1($8
*XLGHOLQHVRQ3HQLOH&DQFHU(GQSUHVHQWHGDWWKH($8$QQXDO
&RQJUHVV&RSHQKDJHQ
>@ GH&UHYRLVLHU56OLPDQH.6DQÀOLSSR1%RVVL$$OEDQR0
IURPDORZLQFLGHQFHDUHD8URO2QFRO 'XPDV,HWDO/RQJWHUPUHVXOWVRIEUDFK\WKHUDS\IRUFDUFL-
>@ 0DKHVDQ 7 +HJDUW\ 3. :DWNLQ 1$ $GYDQFHV LQ 3HQLOH QRPDRIWKHSHQLVFRQÀQHGWRWKHJODQV1RU1;,QW-5DGLDW
3UHVHUYLQJ6XUJLFDO$SSURDFKHVLQWKH0DQDJHPHQWRI3HQLOH 2QFRO%LRO3K\V
7XPRUV8URO&OLQ1RUWK$P >@ &KLSROOLQL-<DQ62WWHQKRI65=KX<'UDHJHU'%DXPJDUWHQ
>@ /RQW$3.URRQ%.+RUHQEODV6*DOOHH03%HUNKRI-0HLMHU $6HWDO6XUJLFDOPDQDJHPHQWRISHQLOHFDUFLQRPDLQVLWX
&-HWDO3UHVHQFHRIKLJKULVNKXPDQSDSLOORPDYLUXV'1$LQ UHVXOWVIURPDQLQWHUQDWLRQDOFROODERUDWLYHVWXG\DQGUHYLHZ
SHQLOHFDUFLQRPDSUHGLFWVIDYRUDEOHRXWFRPHLQVXUYLYDO,QW RIWKHOLWHUDWXUH%-8,QW
-&DQFHU >@ 2WWHQKRI65/HRQH$'MDMDGLQLQJUDW56$]L]L0=DUJDU..LGG
>@ &KDX[$&DEDOOHUR&6RDUHV)*XLPDUDHV*&&XQKD,:5HXWHU /&HWDO6XUJLFDODQG2QFRORJLFDO2XWFRPHVLQ3DWLHQWV$IWHU
9HWDO7KHSURJQRVWLFLQGH[DXVHIXOSDWKRORJLFJXLGHIRU 9DVFXODULVHG)ODS5HFRQVWUXFWLRQIRU/RFRUHJLRQDOO\$GYDQFHG
SUHGLFWLRQRIQRGDOPHWDVWDVHVDQGVXUYLYDOLQSHQLOHVTXDPRXV 3HQLOH&DQFHU(XU8URO)RFXV
FHOOFDUFLQRPD$P-6XUJ3DWKRO >@ /HLMWH -$ 9DOGHV 2OPRV 5$ 1LHZHJ 2( +RUHQEODV 6
>@ :LQWHUV%50RVVDQHQ0+ROW6./LQ'::ULJKW-/3UHGLFWRUV Anatomical mapping of lymphatic drainage in penile carcinoma
RI 1RGDO 8SVWDJLQJ LQ &OLQLFDO 1RGH 1HJDWLYH 3DWLHQWV :LWK ZLWK63(&7&7LPSOLFDWLRQVIRUWKHH[WHQWRILQJXLQDOO\PSK
3HQLOH&DUFLQRPD$1DWLRQDO&DQFHU'DWDEDVH$QDO\VLV8URORJ\ QRGHGLVVHFWLRQ(XU8URO
 >@ .RLIPDQ/+DPSO'.RLIPDQ19LGHV$-2UQHOODV$$5DGLFDO
>@ &XELOOD$/7KHUROHRISDWKRORJLFSURJQRVWLFIDFWRUVLQVTXDPRXV open inguinal lymphadenectomy for penile carcinoma: surgical
FHOOFDUFLQRPDRIWKHSHQLV:RUOG-8URO WHFKQLTXH HDUO\ FRPSOLFDWLRQV DQG ODWH RXWFRPHV - 8URO
>@ 9HOD]TXH]()6RVNLQ$%RFN$&RGDV5&DL*%DUUHWR-( 
HW DO (SLWKHOLDO DEQRUPDOLWLHV DQG SUHFDQFHURXV OHVLRQV RI >@ <DR.7X+/L<+4LQ=./LX=:=KRX)-HWDO0RGLÀHG
DQWHULRUXUHWKUDLQSDWLHQWVZLWKSHQLOHFDUFLQRPDDUHSRUW WHFKQLTXH RI UDGLFDO LQJXLQDO O\PSKDGHQHFWRP\ IRU SHQLOH
RIFDVHV0RG3DWKRO FDUFLQRPDPRUELGLW\DQGRXWFRPH-8URO
>@ /HLMWH -$ *DOOHH 0 $QWRQLQL 1 +RUHQEODV 6 (YDOXDWLRQ >@ 6WXLYHU 00 'MDMDGLQLQJUDW 56 *UDDÁDQG 10 9LQFHQW$'
RI FXUUHQW 710 FODVVLÀFDWLRQ RI SHQLOH FDUFLQRPD - 8URO /XFDV&+RUHQEODV6(DUO\ZRXQGFRPSOLFDWLRQVDIWHULQJXLQDO
GLVFXVVLRQ lymphadenectomy in penile cancer: a historical cohort study
>@ 6DLVRUQ , /DZUHQWVFKXN 1 /HHZDQVDQJWRQJ 6 %ROWRQ '0 DQGULVNIDFWRUDQDO\VLV(XU8URO
Fine-needle aspiration cytology predicts inguinal lymph node >@ 3URW]HO &$OFDUD]$ +RUHQEODV 6 3L]]RFDUR * =ORWWD$
PHWDVWDVLV ZLWKRXW DQWLELRWLF SUHWUHDWPHQW LQ SHQLOH FDUFL- +DNHQEHUJ2:/\PSKDGHQHFWRP\LQWKHVXUJLFDOPDQDJHPHQW
QRPD%-8,QW RISHQLOHFDQFHU(XU8URO
>@ 6DYRLH3+ )OHFKRQ$ 0RUHO-RXUQHO 1 0XUH]7 )HUUHWWL / >@ 7KXUHW 5 6XQ 0 /XJKH]]DQL * %XGDXV / /LEHUPDQ '
&DPSDUR 3 HW DO >)UHQFK FF$)8 JXLGHOLQHV ² 8SGDWH  $EGROODK)HWDO$FRQWHPSRUDU\SRSXODWLRQEDVHGDVVHVVPHQW
3HQLOHFDQFHU@3URJ8URO5 RIWKHUDWHRIO\PSKQRGHGLVVHFWLRQIRUSHQLOHFDUFLQRPD$QQ
>@ .ULVKQD 53 6LVWOD 6& 6PLOH 5 .ULVKQDQ 5 6RQRJUDSK\ DQ 6XUJ2QFRO
XQGHUXWLOL]HGGLDJQRVWLFWRROLQWKHDVVHVVPHQWRIPHWDVWDWLF >@ :HOGULFN&%DVKDU.2·6XOOLYDQ7$*LOOLV(&ODUNH0RORQH\0
JURLQQRGHV-&OLQ8OWUDVRXQG 7DQJ7<HWDO$FRPSDULVRQRIÀEULQVHDODQWYHUVXVVWDQGDUG
>@ +DNHQEHUJ2:0LQKDV61HFFKL$3URW]HO&:DWNLQ1($8 FORVXUHLQWKHUHGXFWLRQRISRVWRSHUDWLYHPRUELGLW\DIWHUJURLQ
*XLGHOLQHVRQ3HOLQH&DQFHU(GQSUHVHQWHGDWWKH($8$QQXDO GLVVHFWLRQ$V\VWHPDWLFUHYLHZDQGPHWDDQDO\VLV(XU-6XUJ
&RQJUHVV&RSHQKDJHQ 2QFRO
>@ 2WWHQKRI 65 9HJW (7KH UROH RI 3(7&7 LPDJLQJ LQ SHQLOH >@ 7DXEHU56FKPLG6+RUQ77KDOJRWW0+HFN0+DOOHU%HWDO
FDQFHU7UDQVO$QGURO8URO ,QJXLQDOO\PSKQRGHGLVVHFWLRQHSLGHUPDOYDFXXPWKHUDS\IRU
>@ 6DGHJKL 5 *KRODPL + =DNDYL 65 .DNKNL 95 +RUHQEODV 6 SUHYHQWLRQRIZRXQGFRPSOLFDWLRQV-3ODVW5HFRQVWU$HVWKHW
$FFXUDF\ RI ))'* 3(7&7 IRU GLDJQRVLQJ LQJXLQDO O\PSK 6XUJ
QRGHLQYROYHPHQWLQSHQLOHVTXDPRXVFHOOFDUFLQRPDV\VWH- >@ *NHJNHV,'0LQLV((,DYD]]R&5RERWLFDVVLVWHGLQJXLQDOO\P-
PDWLF UHYLHZ DQG PHWDDQDO\VLV RI WKH OLWHUDWXUH &OLQ 1XFO SKDGHQHFWRP\DV\VWHPDWLFUHYLHZ-5RERW6XUJ
0HG >@ *UDDÁDQG10YDQ%RYHQ++YDQ:HUNKRYHQ(0RRQHQ/0
>@ =RX=-/LX=+7DQJ/<:DQJ<-/LDQJ-<=KDQJ5&HWDO +RUHQEODV63URJQRVWLFVLJQLÀFDQFHRIH[WUDQRGDOH[WHQVLRQ
5DGLRFROORLGEDVHG G\QDPLF VHQWLQHO O\PSK QRGH ELRSV\ LQ LQSDWLHQWVZLWKSDWKRORJLFDOQRGHSRVLWLYHSHQLOHFDUFLQRPD
SHQLOHFDQFHUZLWKFOLQLFDOO\QHJDWLYHLQJXLQDOO\PSKQRGHDQ -8URO
XSGDWHGV\VWHPDWLFUHYLHZDQGPHWDDQDO\VLV,QW8URO1HSKURO >@ .XONDUQL-1.DPDW053URSK\ODFWLFELODWHUDOJURLQQRGHGLVVHFWLRQ
 YHUVXVSURSK\ODFWLFUDGLRWKHUDS\DQGVXUYHLOODQFHLQSDWLHQWVZLWK
>@ 6DKGHY9$OEHUVHQ0&KULVWRGRXOLGRX03DUQKDP$0DORQH3 1DQG1$FDUFLQRPDRIWKHSHQLV(XU8URO
1LJDP 5 HW DO 0DQDJHPHQW RI QRQYLVXDOL]DWLRQ IROORZLQJ >@ /XFN\0$5RJHUV%3DUU1-5HIHUUDOVLQWRDGHGLFDWHG%ULWLVK
G\QDPLFVHQWLQHOO\PSKQRGHELRSV\IRUVTXDPRXVFHOOFDUFL- SHQLOHFDQFHUFHQWUHDQGVRXUFHVRISRVVLEOHGHOD\6H[7UDQVP
QRPDRIWKHSHQLV%-8,QW ,QIHFW
>@ 1&&11&&1&OLQLFDO3UDFWLFH*XLGHOLQHVLQ2QFRORJ\9HUVLRQ >@ 3URW]HO & +DNHQEHUJ 2: &KHPRWKHUDS\ LQ SDWLHQWV ZLWK
PDUFK SHQLOHFDUFLQRPD8URO,QW
)UHQFKFF$)8JXLGHOLQHVîXSGDWHSHQLOHFDQFHU S279

>@ 3L]]RFDUR*3LYD/$GMXYDQWDQGQHRDGMXYDQWYLQFULVWLQHEOHR- >@ *RWVDG]H'0DWYHHY%=DN%0DPDODG]H9,VFRQVHUYDWLYH

P\FLQDQGPHWKRWUH[DWHIRULQJXLQDOPHWDVWDVHVIURPVTXDPRXV RUJDQVSDULQJ WUHDWPHQW RI SHQLOH FDUFLQRPD MXVWLÀHG" (XU
FHOOFDUFLQRPDRIWKHSHQLV$FWD2QFROE 8URO
>@ /HLMWH -$ .HUVW -0 %DLV ( $QWRQLQL 1 +RUHQEODV 6 >@ 0RVHV.$:LQHU$6IDNLDQRV-33RRQ6$.HQW0%HUQVWHLQ
1HRDGMXYDQW FKHPRWKHUDS\ LQ DGYDQFHG SHQLOH FDUFLQRPD 0HWDO&RQWHPSRUDU\PDQDJHPHQWRISHQLOHFDQFHUJUHDWHU
(XU8URO WKDQ\HDU06.&&H[SHULHQFH&DQ-8URO
>@ %HUPHMR&%XVE\-(6SLHVV3(+HOOHU/3DJOLDUR/&3HWWDZD\ >@ 5HHV 5: )$ %RUOH\ 1 HW DO S7 SHQLOH VTXDPRXV FHOO FDU-
&$1HRDGMXYDQWFKHPRWKHUDS\IROORZHGE\DJJUHVVLYHVXUJLFDO FLQRPDV FDYHUQRVXV YV VSRQJLRVXV LQYDVLRQ (XU 8URO 6XSSO
FRQVROLGDWLRQIRUPHWDVWDWLFSHQLOHVTXDPRXVFHOOFDUFLQRPD 
-8URO >@ /XFN\00XUWK\.95RJHUV%-RQHV6/DX0:6DQJDU9.
>@ 3L]]RFDUR * 1LFRODL 1 0LODQL $ 7D[DQHV LQ FRPELQDWLRQ HWDO7KHWUHDWPHQWRISHQLOHFDUFLQRPDLQVLWX&,6ZLWKLQD
ZLWK FLVSODWLQ DQG ÁXRURXUDFLO IRU DGYDQFHG SHQLOH FDQFHU 8.VXSUDUHJLRQDOQHWZRUN%-8,QW
SUHOLPLQDU\UHVXOWV(XU8URO >@ )ULPEHUJHU'+XQJHUKXEHU(=DDN':DLGHOLFK5+RIVWHWWHU$
>@ 3DJOLDUR /& :LOOLDPV '/ 'DOLDQL ' :LOOLDPV 0% 2VDL : 6FKQHHGH33HQLOHFDUFLQRPD,V1G<$*ODVHUWKHUDS\UDGLFDO
.LQFDLG 0 HW DO 1HRDGMXYDQW SDFOLWD[HO LIRVIDPLGH DQG HQRXJK"-8UROGLVFXVVLRQ
FLVSODWLQFKHPRWKHUDS\IRUPHWDVWDWLFSHQLOHFDQFHUDSKDVH,, >@ %DXPJDUWHQ$&KLSROOLQL-<DQ62WWHQKRI657DQJ'+'UDHJHU
VWXG\-&OLQ2QFRO 'HWDO3HQLOH6SDULQJ6XUJHU\IRU3HQLOH&DQFHU$0XOWLFHQWHU
>@ ,FKLNDZD71DNDQR,+LURNDZD,%OHRP\FLQWUHDWPHQWRIWKH ,QWHUQDWLRQDO5HWURVSHFWLYH&RKRUW-8URO
WXPRUVRISHQLVDQGVFURWXP-8URO >@ $OEHUVHQ03DUQKDP$-RQLDX66DKGHY9&KULVWRGRXOLGRX0
>@ +DDV*3%OXPHQVWHLQ%$*DJOLDQR5*5XVVHOO&$5LYNLQ6( &DVWLJOLRQH)HWDO3UHGLFWLYHIDFWRUVIRUORFDOUHFXUUHQFHDIWHU
&XONLQ'-HWDO&LVSODWLQPHWKRWUH[DWHDQGEOHRP\FLQIRUWKH JODQVHFWRP\DQGQHRJODQVUHFRQVWUXFWLRQIRUSHQLOHVTXDPRXV
WUHDWPHQWRIFDUFLQRPDRIWKHSHQLVD6RXWKZHVW2QFRORJ\ FHOOFDUFLQRPD8URO2QFRO
*URXSVWXG\-8URO >@ 3LPHQWD$ *XWLHUUH] & 0RVTXHUD ' 3HUD - 0DUWLQH] (
>@ +DNHQEHUJ2:1LSSJHQ-%)URHKQHU0=DVWURZ6:LUWK03 /RQGUHV%HWDO3HQLOHEUDFK\WKHUDS\5HWURVSHFWLYHUHYLHZ
&LVSODWLQPHWKRWUH[DWHDQGEOHRP\FLQIRUWUHDWLQJDGYDQFHG RIDVLQJOHLQVWLWXWLRQ%UDFK\WKHUDS\
SHQLOHFDUFLQRPD%-8,QW >@ (VFDQGH$ +DLH0HGHU & 0D]HURQ 5 0DURXQ 3 &DYDOFDQWL
>@ 'MDMDGLQLQJUDW 56 %HUJPDQ$0 YDQ :HUNKRYHQ ( 9HJW ( $ GH &UHYRLVLHU 5 HW DO %UDFK\WKHUDS\ IRU &RQVHUYDWLYH
+RUHQEODV 6 1HRDGMXYDQW WD[DQHEDVHG FRPELQDWLRQ FKH- 7UHDWPHQW RI ,QYDVLYH 3HQLOH &DUFLQRPD 3URJQRVWLF )DFWRUV
PRWKHUDS\ LQ SDWLHQWV ZLWK DGYDQFHG SHQLOH FDQFHU &OLQ DQG/RQJ7HUP$QDO\VLVRI2XWFRPH,QW-5DGLDW2QFRO%LRO
*HQLWRXULQ&DQFHU 3K\V
>@ 1LFKROVRQ 6 +DOO ( +DUODQG 6- &KHVWHU -' 3LFNHULQJ / >@ /RSHV$5RVVL%0)RQVHFD)30RULQL68QUHOLDELOLW\RIPRGL-
%DUEHU-HWDO3KDVH,,WULDORIGRFHWD[HOFLVSODWLQDQG)8 ÀHGLQJXLQDOO\PSKDGHQHFWRP\IRUFOLQLFDOVWDJLQJRISHQLOH
FKHPRWKHUDS\LQORFDOO\DGYDQFHGDQGPHWDVWDWLFSHQLVFDQFHU FDUFLQRPD&DQFHU
&58.%U-&DQFHU >@ )RVVD6'+DOO.6-RKDQQHVVHQ1%8UQHV7.DDOKXV2&DQFHU
>@ .LUUDQGHU3$QGUHQ2:LQGDKO7'\QDPLFVHQWLQHOQRGHELRSV\ RI WKH SHQLV ([SHULHQFH DW WKH 1RUZHJLDQ 5DGLXP +RVSLWDO
LQ SHQLOH FDQFHU LQLWLDO H[SHULHQFHV DW D 6ZHGLVK UHIHUUDO (XU8URO
FHQWUH%-8,QW3W%( >@ /L=6<DR.&KHQ3=RX=-4LQ=./LX=:HWDO'LVHDVH
>@ 'MDMDGLQLQJUDW567HHUWVWUD+-YDQ:HUNKRYHQ(YDQ%RYHQ VSHFLÀF VXUYLYDO DIWHU UDGLFDO O\PSKDGHQHFWRP\ IRU SHQLOH
++ +RUHQEODV 6 8OWUDVRXQG H[DPLQDWLRQ DQG ÀQH QHHGOH FDQFHUSUHGLFWLRQE\O\PSKQRGHFRXQWDQGGHQVLW\8URO2QFRO
DVSLUDWLRQF\WRORJ\XVHIXOIRUIROORZXSRIWKHUHJLRQDOQRGHV 
LQSHQLOHFDQFHU"-8URO >@ -DNREVHQ-..UDUXS.36RPPHU31HUVWURP+%DNKROGW9
>@ 2PRUSKRV66DDG=$U\D0)UHHPDQ$0DORQH31LJDP5 6RUHQVHQ-$HWDO'D3H&DGLDJQRVWLFDFFXUDF\RIVHQWLQHO
HWDO)HDVLELOLW\RISHUIRUPLQJG\QDPLFVHQWLQHOO\PSKQRGH O\PSKQRGHELRSV\LQSDWLHQWVZLWKSHQLOHFDQFHUDWIRXU
ELRSV\DVDGHOD\HGSURFHGXUHLQSHQLOHFDQFHU:RUOG-8URO WHUWLDU\UHIHUUDOFHQWUHV²DQDWLRQDOVWXG\IURP'HQPDUN%-8
 ,QW
>@ 'L /RUHQ]R * )HGHULFR 3 %XRQHUED & /RQJR 1 &DUWHQL * >@ &XELOOD$/%DUUHWR-&DEDOOHUR&$\DOD*5LYHURV03DWKRORJLF
$XWRULQR5HWDO3DFOLWD[HOLQSUHWUHDWHGPHWDVWDWLFSHQLOHFDQ- IHDWXUHVRIHSLGHUPRLGFDUFLQRPDRIWKHSHQLV$SURVSHFWLYH
FHUÀQDOUHVXOWVRIDSKDVHVWXG\(XU8URO VWXG\RIFDVHV$P-6XUJ3DWKRO
>@ =KDQJ6=KX<<H'3KDVH,,VWXG\RIGRFHWD[HOFLVSODWLQDQG >@ &KDX[$6RDUHV)5RGULJXH],%DUUHWR-/H]FDQR&7RUUHV-
ÁXRURXUDFLOLQSDWLHQWVZLWKGLVWDQWO\PHWDVWDWLFSHQLOHFDQFHU HW DO 3DSLOODU\ VTXDPRXV FHOO FDUFLQRPD QRW RWKHUZLVH
DVÀUVWOLQHFKHPRWKHUDS\2QFRWDUJHW VSHFLILHG 126 RI WKH SHQLV FOLQLFRSDWKRORJLF IHDWXUHV
>@ 8GDJHU$0/LX7<6NDOD6/0DJHUV0-0F'DQLHO$66SUDWW GLIIHUHQWLDO GLDJQRVLV DQG RXWFRPH RI  FDVHV$P - 6XUJ
'(HWDO)UHTXHQW3'/H[SUHVVLRQLQSULPDU\DQGPHWDVWDWLF 3DWKRO
SHQLOHVTXDPRXVFHOOFDUFLQRPDSRWHQWLDORSSRUWXQLWLHVIRU >@ .LHIIHU-0'MDMDGLQLQJUDW56YDQ0XLOHNRP($*UDDÁDQG10
LPPXQRWKHUDSHXWLFDSSURDFKHV$QQ2QFRO +RUHQEODV6$DURQVRQ1.4XDOLW\RIOLIHIRUSDWLHQWVWUHDWHG
>@ 'MDMDGLQLQJUDW56YDQ:HUNKRYHQ(0HLQKDUGW:YDQ5KLMQ IRUSHQLOHFDQFHU-8URO
%:%H[$YDQGHU3RHO+*HWDO3HQLOHVSDULQJVXUJHU\IRU >@ 6NHSSQHU ( :LQGDKO 7 $QGHUVVRQ 62 )XJO0H\HU .6
SHQLOHFDQFHUGRHVLWDIIHFWVXUYLYDO"-8URO 7UHDWPHQWVHHNLQJ DVSHFWVRIVH[XDODFWLYLW\ DQGOLIH VDWLV-
>@ 3DROL-7HUQHVWHQ%UDWHO$/RZKDJHQ*%6WHQTXLVW%)RUVOXQG IDFWLRQLQPHQZLWKODVHUWUHDWHGSHQLOHFDUFLQRPD(XU8URO
2:HQQEHUJ$03HQLOHLQWUDHSLWKHOLDOQHRSODVLDUHVXOWVRI 
SKRWRG\QDPLFWKHUDS\$FWD'HUP9HQHUHRO >@ 2·.HOO\)/RQHUJDQ3/XQGRQ'1DVRQ*6ZHHQH\3&XOOHQ,
>@ 2UQHOODV$$.LQFKLQ(:1REUHJD%/:LVQHVFN\$.RLIPDQ1 HWDO$3URVSHFWLYH6WXG\RI7RWDO*ODQV5HVXUIDFLQJIRU/RFDOL]HG
4XLULQR 5 6XUJLFDO WUHDWPHQW RI LQYDVLYH VTXDPRXV FHOO 3HQLOH&DQFHUWR0D[LPL]H2QFRORJLFDQG)XQFWLRQDO2XWFRPHV
FDUFLQRPD RI WKH SHQLV %UD]LOLDQ 1DWLRQDO &DQFHU ,QVWLWXWH LQD7HUWLDU\5HIHUUDO1HWZRUN-8URO
ORQJWHUPH[SHULHQFH-6XUJ2QFRO >@ <DQJ - &KHQ - :X ;) 6RQJ 1- ;X ;< /L 4 HW DO *ODQV
>@ 9HHUDWWHUDSLOOD\ 57HR /$VWHUOLQJ 6 *UHHQH ' 2QFRORJLF SUHVHUYDWLRQFRQWULEXWHVWRSRVWRSHUDWLYHUHVWRUDWLRQRIPDOH
2XWFRPHVRI3HQLOH&DQFHU7UHDWPHQWDWD8.6XSUDUHJLRQDO VH[XDOIXQFWLRQDPXOWLFHQWHUFOLQLFDOVWXG\RIJODQVSUHVHUYLQJ
&HQWHU8URORJ\ VXUJHU\-8URO